rfhg_41444.1

Basic information about the TSS

---

TSS ID: rfhg_41444.1 Species: human Chr: chr2		Start: 241271945 End: 241271973 Strand: -
Source datasets
Protocol
TSS cluster detected*	3

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3267477,EH38E2090535)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000444092.5:0 GeneID: 3069 HGNC/MGI_ID: HGNC:4857 UniProt_ID: C9JES8 Nearer transcript ids and distances:

Gene_name: HDLBP Gene_symbol: HDLBP Gene_synonyms: HBP Gene_source: HGNC:4857

TATA-Box annotation

---

Distance to TSS:	6
Nearest PromoterID:	NM_001320966
Entrez ID:	3069
Nearest Unigene:	Hs.471851
Nearest Refseq:	NM_005336
Nearest Ensembl:	ENSG00000115677
Gene Name:	HDLBP
Gene Alias:	HBP|PRO2900|VGL
Gene Type:	protein-coding
CpG%:	0.035714
GC%:	0.551724
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HDLBP p2@HDLBP p3@HDLBP p4@HDLBP p5@HDLBP p6@HDLBP p7@HDLBP p9@HDLBP p10@HDLBP
Sample		p1@HDLBP	p2@HDLBP	p3@HDLBP	p4@HDLBP	p5@HDLBP	p6@HDLBP	p7@HDLBP	p9@HDLBP	p10@HDLBP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	27.86	42.86	5.45	4.09	0.39	0.39	0.39	0.19	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	29.74	42.49	3.64	4.65	0.00	1.01	0.61	0.81	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	31.64	49.58	4.44	6.94	0.39	1.16	0.19	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	29.52	37.22	2.91	3.33	0.00	0.83	0.42	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	41.17	42.74	4.95	2.47	0.45	0.22	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.34	39.34	4.07	3.49	0.19	0.19	0.19	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	37.04	62.75	7.41	4.36	0.00	1.74	0.65	0.22	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	26.64	50.14	4.84	4.84	0.73	0.48	0.24	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	28.42	45.95	4.27	6.84	0.43	0.00	0.64	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	35.36	64.92	7.54	7.54	0.00	0.00	0.58	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	31.93	70.74	6.87	6.87	0.81	1.21	0.00	0.40	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	38.22	56.92	9.76	6.91	0.41	0.81	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	64.15	37.07	45.13	4.03	0.48	0.64	0.48	1.13	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	65.25	42.55	39.39	3.61	0.60	1.80	0.60	1.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	55.11	28.32	43.91	2.85	0.66	1.32	0.66	1.54	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	62.12	32.19	34.96	2.77	0.25	2.01	1.26	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	52.64	43.24	40.41	2.62	1.09	1.31	1.09	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	57.37	37.96	40.49	2.95	0.42	1.27	1.27	1.27	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	51.72	36.79	31.46	4.27	1.07	1.07	1.07	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	61.08	26.93	40.32	4.06	0.90	1.50	0.15	1.65	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	61.21	36.62	37.16	4.54	1.07	0.94	0.94	1.60	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	60.42	32.80	41.95	3.45	1.21	1.55	1.55	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	62.95	41.49	41.23	2.59	0.78	1.29	0.52	0.65	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	56.78	31.30	34.94	3.64	0.73	0.73	0.97	1.70	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	57.02	35.60	45.41	2.58	2.32	0.77	1.03	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	52.54	40.51	33.23	2.22	2.53	1.27	0.00	0.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	59.89	37.91	30.22	2.75	0.55	2.20	1.65	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	78.74	32.77	36.78	5.66	0.47	2.83	0.24	0.71	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	54.76	28.59	36.83	2.75	1.13	0.81	0.48	0.65	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	65.69	37.82	40.54	2.90	0.54	1.09	1.27	1.09	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	54.43	30.56	33.49	2.09	0.84	1.47	0.42	1.26	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	57.25	32.43	33.41	2.74	0.98	0.78	0.39	0.78	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	55.50	37.99	35.03	4.01	1.06	0.21	0.21	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	64.00	52.12	28.70	5.28	0.82	1.48	1.65	0.66	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	62.27	28.42	33.85	3.55	0.75	1.12	0.93	1.31	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	59.59	34.49	40.24	3.45	0.77	1.53	0.77	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	57.84	32.91	41.90	3.27	1.02	1.84	1.23	2.25	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	55.41	38.89	40.30	2.42	1.01	0.81	0.81	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	63.47	31.06	35.92	4.59	0.54	1.35	1.08	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	55.45	30.01	32.17	2.88	1.92	1.44	0.48	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	60.46	32.70	39.05	2.12	0.47	1.88	0.00	0.71	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	59.73	41.87	33.67	4.54	1.17	1.17	1.32	0.73	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	60.10	28.47	37.75	3.37	0.63	1.05	0.63	1.69	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	58.92	35.14	36.36	2.97	0.87	1.40	0.70	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	59.63	27.51	37.54	3.21	0.20	0.80	0.80	1.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	53.74	33.50	36.53	3.95	1.16	1.63	0.93	0.93	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	59.26	31.43	37.19	3.36	1.68	0.48	1.20	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	54.25	29.21	33.38	2.38	1.49	1.49	0.89	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	55.30	37.10	42.37	2.15	1.20	0.48	0.48	1.44	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	56.82	36.60	39.83	4.45	2.22	1.01	0.61	1.21	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	61.69	37.71	35.66	3.48	1.43	1.43	0.82	1.64	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	78.05	48.26	42.03	5.34	2.89	4.67	0.22	2.67	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	139.92	69.96	41.98	13.99	0.00	27.98	0.00	27.98	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	69.20	46.13	50.03	7.45	2.84	1.77	0.00	1.42	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	80.53	47.72	39.43	4.31	2.32	2.65	1.33	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	55.37	59.56	17.62	14.26	5.87	10.07	5.87	3.36	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	71.64	51.89	27.10	7.35	5.05	5.51	0.92	1.38	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	85.89	57.69	54.77	3.89	4.21	2.59	2.27	1.62	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	87.04	41.43	52.67	6.10	1.61	2.89	0.32	0.96	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	98.39	66.95	36.15	8.80	4.09	3.14	0.94	3.46	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	119.15	62.04	41.60	4.94	2.12	2.12	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	93.09	56.08	49.35	5.05	4.49	5.05	0.56	1.68	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	81.21	62.90	19.11	16.72	9.55	9.55	0.80	6.37	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	98.19	63.88	33.64	7.47	2.38	2.72	0.68	2.04	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	93.25	38.99	42.56	4.22	3.90	1.30	0.00	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	93.36	33.37	41.53	4.97	3.55	1.42	1.06	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	129.31	113.15	16.16	64.66	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	205.33	118.46	94.77	23.69	23.69	0.00	0.00	23.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	103.84	46.31	50.70	4.39	3.90	3.41	0.49	0.98	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	108.60	38.18	41.16	3.47	3.97	1.49	1.49	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	122.44	45.50	48.79	3.28	2.35	0.00	0.94	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	85.45	43.72	36.76	7.95	3.31	0.99	0.33	1.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	92.49	44.24	47.02	1.55	2.17	1.24	1.86	1.55	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	101.51	43.11	53.51	3.67	3.06	0.92	0.92	0.61	1.22
Adipocyte - breast, donor1	11376-118A8	157.75	72.54	52.43	5.23	7.60	0.95	3.64	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	97.54	70.91	24.06	4.01	6.74	5.45	1.76	2.89	2.09
Adipocyte - omental, donor1	11473-119C6	163.49	96.06	63.61	8.14	10.31	1.40	1.78	1.15	0.89
Adipocyte - omental, donor2	11474-119C7	78.49	44.85	44.10	3.74	4.48	2.99	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	90.76	35.50	42.53	4.35	3.35	0.67	1.34	1.34	1.00
Adipocyte - perirenal, donor1	11476-119C9	109.73	56.78	45.30	1.91	6.38	1.91	5.74	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	42.88	24.19	17.59	4.40	3.30	0.00	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	132.78	45.16	19.87	6.32	10.84	1.35	1.81	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	84.11	41.88	32.32	3.65	5.91	1.04	0.70	0.17	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	147.27	67.28	63.17	4.30	9.39	0.39	0.98	0.98	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	101.15	32.69	32.69	2.32	4.63	1.29	0.77	0.26	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	122.10	46.28	36.24	4.18	4.46	0.00	1.67	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	81.71	35.27	38.80	4.70	4.11	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	72.07	66.60	55.58	4.34	4.42	0.56	0.97	0.32	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	61.97	35.18	33.89	1.94	3.87	0.97	1.29	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	81.04	44.79	35.19	3.73	4.27	1.60	0.53	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	65.10	40.62	41.73	2.78	5.56	0.56	1.11	0.56	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	38.68	33.27	36.18	0.83	1.25	1.25	1.25	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	43.70	35.16	28.13	2.76	2.01	1.00	0.50	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	45.81	38.94	40.25	2.62	3.93	0.33	0.65	0.33	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	28.01	38.06	43.84	2.13	1.52	0.00	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	49.95	68.95	27.18	7.73	1.10	0.44	0.22	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	14.70	19.00	11.47	2.15	0.36	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	25.16	7.19	5.99	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	81.86	48.75	37.24	10.07	3.78	1.44	0.00	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	82.00	28.45	28.45	1.67	5.02	1.67	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	74.37	40.47	32.67	2.67	4.31	1.44	0.62	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	146.24	99.32	54.01	5.03	5.84	1.26	1.95	0.34	1.14
Anulus Pulposus Cell, donor2	11463-119B5	92.57	41.63	53.88	4.41	3.67	1.22	0.98	0.24	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	93.90	39.54	32.35	2.70	4.94	0.45	1.80	3.59	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	108.10	46.45	44.72	2.17	4.78	2.17	1.74	2.60	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	98.45	34.24	32.10	4.28	4.28	2.14	2.14	4.28	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	107.31	49.02	43.94	6.28	5.08	0.90	2.39	0.00	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	96.11	39.20	40.47	12.65	3.79	1.26	2.53	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	85.15	42.90	34.32	3.30	5.94	3.30	0.66	1.32	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	88.04	40.94	33.14	4.22	6.17	0.32	0.97	0.32	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	88.84	49.03	32.04	3.88	3.40	0.49	0.97	1.94	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	76.02	43.95	26.72	1.78	5.34	3.56	1.19	0.00	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	99.06	51.22	42.56	2.64	6.40	1.13	1.88	0.00	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	79.10	36.28	34.83	3.63	5.08	2.18	0.73	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	77.73	47.64	28.84	2.51	1.25	1.25	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	106.09	63.42	42.01	2.80	6.92	0.99	0.00	0.16	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	87.35	39.58	36.85	9.55	4.09	2.73	1.36	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	88.06	39.05	31.82	4.22	4.67	0.45	0.30	0.00	1.36
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	90.55	40.72	33.75	2.68	4.82	1.07	0.54	1.61	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	102.97	39.68	39.49	4.53	5.86	1.32	0.94	0.57	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	95.15	51.59	38.22	2.94	6.41	3.21	1.07	0.53	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	61.45	30.24	39.02	0.98	2.93	0.00	0.98	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	99.35	40.30	37.98	2.82	5.31	1.33	0.66	1.33	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	68.44	44.43	26.42	1.20	1.20	2.40	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	7.08	35.40	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	113.90	48.71	44.94	4.46	5.66	1.72	1.03	1.20	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	67.12	50.34	16.78	0.00	4.19	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	106.79	39.32	34.47	4.85	4.37	1.46	2.43	1.46	3.40
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	111.18	57.68	49.71	6.45	8.73	1.90	1.14	0.38	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	76.32	30.28	26.65	3.63	3.63	3.63	1.21	2.42	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	92.35	39.90	34.77	6.27	3.42	1.14	1.14	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	102.83	44.47	38.69	3.42	7.05	1.28	0.86	1.28	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	79.75	31.49	27.10	4.13	5.42	0.77	1.29	1.03	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	94.31	50.67	30.03	6.10	6.10	1.41	0.47	0.94	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	86.82	39.87	44.37	3.22	4.18	1.29	0.64	0.64	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	73.49	36.39	34.25	2.14	2.85	2.14	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	83.06	31.59	36.85	4.68	0.58	1.75	1.75	0.00	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	102.06	49.98	35.83	5.72	3.61	0.90	1.51	1.51	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	70.09	49.90	43.96	3.56	3.56	0.00	1.19	3.56	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	99.68	45.26	37.12	7.12	4.07	2.03	2.54	2.03	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	109.26	52.98	39.22	5.60	6.62	3.31	2.29	0.76	3.06
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	57.82	41.30	31.13	3.18	5.08	0.00	1.91	0.00	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	83.72	41.43	33.23	6.04	6.47	0.43	1.73	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	92.51	41.07	37.89	2.54	6.14	1.91	0.42	1.48	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	64.38	34.51	23.49	2.90	2.32	0.87	1.16	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	100.14	42.51	34.01	1.89	3.78	4.72	0.94	3.78	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	86.80	42.55	37.30	1.86	3.90	1.86	0.51	0.51	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	81.07	48.64	27.80	0.00	2.32	0.00	2.32	0.00	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	78.17	52.81	50.70	4.23	2.11	0.00	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	98.63	50.17	37.09	4.72	4.50	1.72	0.86	0.64	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	73.40	49.94	24.07	4.21	5.41	1.80	1.20	0.00	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	78.73	28.43	31.35	1.46	5.83	1.46	1.46	0.00	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	102.07	52.18	43.91	4.83	6.90	0.46	1.15	1.15	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	56.11	48.46	28.05	10.20	5.10	0.00	5.10	5.10	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	77.29	45.51	36.61	3.81	3.56	0.51	0.25	0.00	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	103.63	51.40	44.18	4.54	4.54	1.24	1.24	0.41	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	90.88	43.76	31.21	4.59	3.67	3.06	1.84	1.22	2.14
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	111.85	41.59	38.72	4.30	6.69	2.39	0.96	1.43	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	99.78	51.22	42.13	5.77	5.99	2.22	0.44	1.11	1.77
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	59.51	39.67	18.31	3.05	6.10	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	91.39	36.56	32.13	2.77	4.98	0.55	2.22	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	104.59	45.02	43.69	5.83	5.30	1.32	0.79	0.79	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	83.23	39.25	31.98	1.82	2.54	1.09	0.00	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	46.55	56.62	44.21	8.35	3.32	0.12	0.25	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	36.46	25.85	29.44	4.28	0.68	0.17	0.34	0.00	0.34
Astrocyte - cerebellum, donor3	11661-122F5	37.54	19.51	36.08	1.68	0.63	0.21	0.42	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	57.87	46.01	56.82	3.83	0.70	1.05	0.00	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	57.43	56.62	47.72	7.93	1.94	1.13	0.65	0.81	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	94.12	48.33	59.07	6.26	2.68	1.64	0.89	0.60	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	29.70	102.53	16.06	8.72	1.72	1.95	0.34	1.26	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	28.69	122.90	13.03	8.39	2.00	1.75	0.25	0.88	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	26.06	113.91	15.59	7.85	2.16	0.68	1.02	0.68	1.14
Basophils, donor1	12241-129G9	8.89	30.60	6.80	0.52	1.83	0.26	0.00	0.00	0.00
Basophils, donor2	12242-129H1	7.22	33.91	8.66	0.36	1.08	0.00	0.00	0.00	0.36
Basophils, donor3	12243-129H2	20.58	30.72	23.96	1.03	0.59	0.00	0.15	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	32.56	35.79	24.36	2.37	0.43	0.00	0.43	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	12.34	10.06	7.77	1.37	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	78.91	28.69	0.00	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	27.62	51.47	13.18	5.02	0.63	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	56.56	58.43	25.16	5.82	0.62	0.62	0.42	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	71.85	47.90	43.76	6.91	0.92	0.69	0.69	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	45.71	52.72	34.55	6.12	1.62	1.80	0.36	0.72	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	114.60	44.11	3.61	0.00	0.62	0.10	0.41	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	19.56	94.56	60.32	3.26	0.47	0.70	0.00	0.47	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	15.35	32.94	32.30	3.52	1.28	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	41.37	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	10.71	28.18	18.03	1.13	0.00	0.00	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	8.72	29.88	18.93	1.11	0.56	0.74	0.56	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	10.32	20.64	17.78	1.32	0.44	0.00	0.00	0.44	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	32.83	85.76	37.36	2.83	1.70	0.57	1.42	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	31.46	83.02	26.91	4.55	1.14	0.76	0.38	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	34.19	92.38	49.64	3.29	1.31	2.30	0.99	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	14.02	52.47	15.47	1.16	0.14	1.01	0.72	0.00	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	14.18	45.56	11.47	0.91	0.60	0.60	0.30	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	17.53	35.30	9.71	1.18	0.47	0.00	0.47	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.24	41.18	7.20	0.84	0.67	0.17	0.33	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	14.35	38.09	8.28	0.28	0.28	0.55	0.28	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	24.30	43.64	5.95	0.99	0.74	0.25	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	10.38	33.09	7.83	0.59	0.20	0.20	0.20	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.83	28.31	10.33	0.36	0.53	0.18	0.18	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	8.71	29.60	7.40	0.44	0.22	0.00	0.00	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	14.05	24.82	7.02	0.00	0.47	0.47	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	21.65	34.85	5.81	0.53	0.00	0.53	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	31.06	43.26	6.66	3.33	0.00	1.11	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	16.51	44.18	9.82	0.74	0.00	0.59	0.45	0.59	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.16	54.88	10.18	1.00	0.60	0.40	0.40	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.91	44.76	7.29	1.67	0.42	0.21	0.21	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	15.79	46.21	5.72	1.14	0.00	0.23	0.23	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	11.76	44.11	6.56	0.23	0.23	0.23	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	16.59	31.86	7.42	0.87	0.87	0.44	0.00	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.07	40.08	8.61	0.54	0.00	0.27	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	7.68	42.04	9.77	0.52	0.17	0.17	0.52	0.17	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	10.94	34.09	8.00	0.00	0.42	0.42	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	12.31	34.17	5.88	0.55	0.00	0.55	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	9.16	28.18	3.87	0.70	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	15.36	31.59	5.70	0.00	0.44	0.00	0.00	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.59	26.85	7.15	0.52	0.17	0.52	0.17	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	8.92	17.84	5.95	0.37	0.37	0.00	0.00	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	13.15	32.76	9.92	0.65	0.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	16.79	43.82	7.37	0.00	0.41	0.41	0.00	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.72	32.22	3.94	0.23	0.23	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	13.69	33.41	5.80	0.46	0.00	0.93	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	3.27	37.71	13.51	1.53	1.31	0.00	0.00	0.44	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	7.39	49.89	16.40	1.15	1.85	0.23	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	4.77	33.58	13.00	1.08	1.95	0.00	0.00	0.00	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	7.47	77.08	25.54	1.71	1.40	0.16	0.16	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	6.99	57.81	23.93	1.40	1.22	0.00	0.00	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	8.92	74.69	23.19	2.23	0.45	0.89	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	5.87	31.90	16.33	2.04	1.02	0.00	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	6.59	41.28	15.15	5.27	1.32	0.00	0.44	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	7.79	31.79	16.63	3.37	1.68	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	18.29	30.48	6.10	0.00	2.03	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	8.81	18.98	11.53	0.00	1.36	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	5.18	24.85	14.50	1.04	0.00	0.00	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	12.79	36.25	15.99	0.53	1.60	0.00	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	8.58	28.41	16.08	0.00	1.61	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.23	18.95	11.93	1.40	0.70	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	7.06	32.94	15.69	0.78	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	6.59	29.00	13.18	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	4.11	24.66	12.33	0.00	0.00	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	3.63	9.43	11.61	0.00	0.73	0.00	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	5.05	21.20	7.07	0.50	1.01	0.50	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	8.08	132.93	57.78	35.56	0.40	1.62	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	7.59	90.68	38.75	21.57	0.40	0.00	0.40	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	10.04	11.04	20.08	1.00	1.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	11.80	14.05	17.42	0.00	0.00	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	16.91	44.71	40.96	6.39	3.01	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	21.42	48.25	34.27	3.83	0.68	0.00	0.00	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	3.57	31.78	34.28	0.36	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	4.90	24.49	21.43	0.61	0.61	0.61	0.61	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	3.96	20.74	22.87	0.30	0.30	0.61	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.77	35.48	22.46	0.51	0.00	0.51	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	2.25	35.71	26.73	1.12	0.45	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1.72	26.45	27.88	0.86	0.00	0.29	0.00	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1.42	22.76	19.91	1.42	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.70	19.67	33.71	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	9.89	23.07	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	8.38	41.19	25.43	3.90	0.72	0.14	0.29	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	5.25	34.91	25.76	2.03	0.51	0.51	0.34	0.51	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	6.45	32.40	23.05	2.42	0.64	0.32	0.16	0.16	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1.79	16.14	18.38	0.90	0.45	0.90	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.35	19.92	17.12	0.70	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.88	31.24	13.20	1.76	0.44	0.44	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	3.37	51.02	24.88	2.95	1.26	0.42	0.00	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	4.36	36.15	23.48	0.83	0.62	0.21	0.42	0.00	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	3.68	29.74	22.72	2.34	1.00	0.00	0.67	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2.45	34.81	27.47	1.09	0.54	0.27	0.27	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	2.68	29.48	37.52	1.61	0.54	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	25.11	37.66	0.00	1.79	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	7.42	49.69	26.70	3.52	0.19	0.37	0.37	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	5.20	40.29	27.94	2.82	0.22	0.22	0.43	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	5.04	35.52	27.95	2.52	1.05	0.63	0.21	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	2.02	26.80	29.33	1.01	0.00	0.00	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	3.03	18.20	23.83	0.43	0.43	0.00	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	3.49	35.30	28.33	0.00	1.31	0.87	0.44	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	2.47	33.65	26.23	0.99	0.99	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1.85	19.39	25.85	0.00	0.00	0.00	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1.40	16.75	19.54	1.40	1.40	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	2.77	37.11	30.74	2.49	1.66	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	3.19	47.61	33.13	1.72	0.98	0.25	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	40.04	26.18	3.08	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	2.86	37.60	30.80	1.07	0.00	0.00	0.72	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	2.77	27.70	20.77	0.00	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	4.58	27.50	24.55	0.33	0.65	0.00	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	6.38	14.64	15.77	0.38	0.00	0.38	0.00	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	2.52	17.93	26.51	0.00	0.25	0.50	0.25	0.76	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	25.23	53.22	7.34	3.67	0.92	1.15	0.69	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	19.17	52.96	8.63	1.20	0.24	1.68	0.48	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	19.42	66.48	7.11	1.92	1.09	1.37	0.82	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	25.52	69.95	7.21	3.60	1.80	0.60	0.30	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	20.88	46.56	6.72	1.92	0.24	0.48	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	18.87	51.39	6.59	2.73	0.68	0.45	0.45	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	21.29	63.01	7.17	5.43	0.65	0.87	0.22	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	21.58	77.12	7.90	3.16	0.53	1.84	0.26	0.26	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	21.81	79.97	6.80	3.05	0.23	0.94	0.47	0.47	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	21.43	58.87	9.06	6.04	1.81	0.91	0.30	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	23.24	56.94	8.13	2.91	0.58	0.87	0.00	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	20.78	43.70	11.46	4.26	0.80	0.80	0.00	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	22.33	27.58	7.00	1.75	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	20.49	23.68	8.65	2.73	0.91	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.92	28.34	5.97	0.75	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	19.81	48.98	6.12	1.44	0.36	0.36	0.72	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.40	47.47	9.21	1.44	1.73	0.58	0.29	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.03	45.73	7.07	2.12	0.94	0.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	18.38	52.61	9.19	5.07	0.95	1.27	0.00	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	13.23	56.28	8.61	4.61	0.92	0.92	1.23	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	12.82	55.78	7.37	3.85	0.64	0.96	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	22.18	46.28	9.94	4.21	1.91	0.76	0.00	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.49	36.65	8.67	4.34	0.39	0.00	0.00	0.00	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	20.42	47.65	5.29	2.27	0.00	0.00	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	33.72	43.36	7.23	5.62	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	20.98	47.56	13.29	6.29	0.70	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	20.04	34.06	18.03	1.00	0.00	0.00	0.00	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	148.05	10.97	47.52	1.83	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	106.72	54.35	23.72	5.93	5.43	1.48	0.99	1.48	0.49
Cardiac Myocyte, donor3	11686-122I3	164.16	73.35	32.41	5.05	5.26	0.21	0.32	0.42	0.63
Chondrocyte - de diff, donor1	11261-116G1	120.99	84.24	72.45	9.36	8.32	1.04	2.43	1.39	0.00
Chondrocyte - de diff, donor2	11338-117F6	129.36	31.98	50.82	5.33	1.07	0.36	2.13	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	115.83	54.61	43.92	3.75	5.35	2.62	1.14	1.25	1.14
Chondrocyte - re diff, donor2	11339-117F7	238.14	76.10	74.31	8.95	18.80	0.90	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	153.67	31.14	74.41	3.64	9.71	2.02	2.43	1.21	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	58.30	76.31	82.63	8.95	3.79	0.69	0.23	0.11	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	69.26	59.64	44.25	4.28	2.78	2.35	1.71	1.07	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	74.25	57.79	63.19	5.49	2.48	2.12	0.35	0.80	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	34.02	93.17	49.98	28.61	2.84	0.73	0.92	0.64	0.18
Corneal Epithelial Cells, donor1	11526-119I5	25.69	22.62	22.84	2.85	0.22	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	30.72	40.95	42.09	1.14	2.28	3.41	1.14	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	28.12	45.50	22.75	4.86	0.51	0.51	0.00	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	23.28	84.53	30.71	2.81	5.28	0.33	0.00	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.97	72.23	31.54	3.47	6.31	0.32	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	51.76	34.51	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	17.28	45.14	32.50	2.81	4.75	0.76	0.11	0.65	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	36.21	20.84	41.00	3.07	1.02	0.34	0.00	0.34	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	24.16	16.32	35.25	5.22	1.31	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	24.68	18.39	25.17	2.42	0.48	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	105.23	74.88	21.01	6.67	2.17	0.67	0.17	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	90.36	39.90	21.71	1.76	1.17	0.00	0.00	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	111.70	65.61	31.11	7.35	0.85	0.57	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	112.06	60.55	29.88	5.11	1.57	0.00	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	80.28	42.76	28.51	3.49	0.87	0.58	0.87	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	95.29	63.76	15.29	6.82	2.82	2.12	1.18	0.71	1.65
Endothelial Cells - Artery, donor3	11413-118E9	119.56	58.90	26.82	4.38	1.93	1.93	0.35	0.70	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	89.99	56.08	31.03	5.10	1.77	1.33	0.66	0.66	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	115.32	67.24	48.99	4.56	1.83	0.00	0.00	0.61	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	128.83	66.81	36.65	3.95	3.66	0.56	0.56	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	65.96	49.92	27.04	6.83	1.78	0.30	2.08	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	83.31	41.65	14.06	2.60	2.08	0.52	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	50.19	28.22	29.07	2.84	0.57	1.42	0.71	0.71	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	109.63	91.63	28.41	14.80	2.00	2.00	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	104.82	39.31	12.58	4.19	1.05	2.10	0.52	0.52	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	151.33	122.13	36.03	10.69	3.11	0.87	0.87	0.87	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	112.98	49.75	28.03	6.30	1.09	0.22	0.65	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	118.46	65.83	26.14	9.40	1.34	0.85	0.12	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	78.49	40.95	12.51	2.28	4.55	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	73.34	39.12	12.57	5.59	2.10	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	120.58	40.35	28.26	5.02	0.63	1.41	0.79	0.31	0.47
Eosinophils, donor1	12244-129H3	0.00	45.74	30.49	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	6.60	155.12	1.65	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	85.60	3.57	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	28.34	30.30	19.55	4.15	0.49	0.49	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	31.20	16.64	35.36	0.00	2.08	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	48.81	48.81	0.00	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	224.96	67.32	48.03	4.93	10.26	1.64	0.82	2.05	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	84.85	46.53	30.33	2.63	6.46	3.28	2.41	1.20	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	155.90	67.82	57.96	5.20	4.77	3.14	1.52	1.84	1.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	178.89	121.04	32.99	6.55	11.28	2.55	2.79	1.33	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	204.30	109.04	19.92	6.69	7.51	0.27	0.55	0.55	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	205.35	64.86	65.07	5.70	8.65	4.54	4.11	2.64	2.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	109.09	68.24	23.19	3.69	2.37	2.37	2.11	0.79	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	149.49	81.06	48.50	9.30	4.65	3.32	0.66	1.99	0.66
Fibroblast - Cardiac, donor1	11268-116G8	138.81	51.71	41.73	5.44	4.99	2.27	1.36	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	225.11	78.83	24.25	7.58	6.82	3.03	1.52	1.52	0.76
Fibroblast - Cardiac, donor3	11417-118F4	120.81	25.08	29.97	2.05	4.10	1.73	0.32	1.10	0.63
Fibroblast - Cardiac, donor4	11452-119A3	226.72	118.52	41.22	11.52	8.18	0.61	0.91	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	127.79	51.27	36.04	6.98	2.28	1.65	0.76	1.14	0.38
Fibroblast - Cardiac, donor6	11460-119B2	103.99	65.03	22.59	4.85	3.34	0.61	1.21	0.76	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	203.53	75.57	39.26	8.44	9.51	0.40	0.94	0.27	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	198.03	49.61	20.71	4.75	4.75	2.59	1.29	1.29	3.02
Fibroblast - Choroid Plexus, donor3	11653-122E6	93.75	55.66	38.08	7.32	4.39	5.86	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	106.56	47.97	46.82	11.99	0.69	0.46	0.46	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	259.66	117.88	89.21	6.28	6.78	2.20	1.36	0.51	0.68
Fibroblast - Dermal, donor1	11269-116G9	104.24	40.38	35.92	4.93	5.87	0.94	2.11	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	108.01	60.37	31.60	10.38	4.25	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	110.37	38.93	36.14	4.59	2.54	1.69	0.85	0.36	0.73
Fibroblast - Dermal, donor4	11450-119A1	123.33	57.54	42.28	10.85	0.90	2.03	1.02	0.57	0.34
Fibroblast - Dermal, donor5	11454-119A5	132.06	61.58	35.07	8.72	1.74	1.22	0.87	0.87	0.70
Fibroblast - Dermal, donor6	11458-119A9	146.02	69.68	36.71	11.86	2.92	0.81	0.32	0.49	0.49
Fibroblast - Gingival, donor1	11237-116D4	211.56	116.40	64.55	12.91	14.16	0.62	0.62	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	193.09	95.11	55.81	10.22	11.53	2.36	1.57	1.05	0.52
Fibroblast - Gingival, donor2	11318-117D4	135.34	65.89	43.09	8.17	3.69	3.16	1.19	1.05	1.58
Fibroblast - Gingival, donor3	11394-118C8	214.64	69.23	81.60	9.96	7.44	0.77	0.68	1.26	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	198.43	54.02	52.98	7.27	9.35	4.16	5.19	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	138.32	46.87	36.30	2.47	5.64	4.05	2.64	1.76	1.59
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	173.98	109.44	39.44	9.98	9.20	2.96	0.94	0.94	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	130.90	91.55	27.59	6.76	6.09	1.49	1.22	0.81	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	69.87	61.05	17.29	5.65	6.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	164.96	122.85	37.58	9.36	10.38	2.63	0.58	0.58	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	182.85	136.35	36.41	10.23	10.36	2.59	0.95	1.36	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	152.14	95.54	32.14	7.02	5.81	2.08	1.10	1.10	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	167.28	66.33	59.14	3.23	7.48	1.03	2.49	1.17	0.00
Fibroblast - Lung, donor1	11270-116H1	84.28	39.42	25.83	4.08	0.00	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	116.39	67.15	40.29	20.89	2.98	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	129.36	48.96	33.55	5.49	0.42	2.95	1.06	0.42	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	150.78	97.46	27.49	11.66	8.33	0.00	1.67	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	109.09	27.97	13.99	1.40	5.59	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	41.70	15.39	9.24	1.40	1.12	0.84	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	281.34	126.66	70.23	20.70	11.77	0.00	0.41	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	51.92	15.98	11.98	7.99	0.00	0.00	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	172.73	53.61	23.83	5.96	11.91	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	173.41	98.54	52.57	15.71	5.24	0.58	0.39	1.16	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	172.01	99.05	47.93	11.68	3.34	3.64	1.97	1.06	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	243.57	149.32	71.30	22.34	13.16	0.00	0.61	0.31	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	148.07	58.39	62.20	4.20	3.05	0.76	0.76	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	154.70	85.86	27.27	6.48	9.45	3.78	1.89	0.54	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	141.60	62.16	39.20	3.83	5.22	1.51	1.39	0.46	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	122.25	87.87	24.21	8.18	4.53	0.99	0.77	0.22	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	155.03	93.47	43.08	17.68	5.89	0.20	1.22	0.00	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	82.19	36.75	21.38	5.35	4.01	0.00	0.67	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	122.56	45.86	32.02	3.56	1.19	0.79	0.00	1.19	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	175.03	88.31	19.45	6.55	3.37	2.18	0.00	1.39	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	210.48	55.06	77.62	3.73	4.26	2.49	0.89	1.24	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	244.78	88.29	81.59	6.31	5.52	2.37	1.18	0.99	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	128.77	101.09	19.25	7.82	6.02	1.81	0.00	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	185.57	113.46	95.97	12.74	10.80	1.84	1.84	1.19	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	204.48	70.10	25.31	5.82	4.81	0.76	0.76	0.76	0.51
Fibroblast - skin normal, donor1	11553-120C5	236.93	88.60	75.31	8.86	6.89	2.46	0.98	1.48	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	197.50	132.94	18.05	8.82	5.81	1.20	0.40	0.20	0.60
Fibroblast - skin normal, donor2	11561-120D4	197.61	128.09	66.00	12.36	10.45	1.81	1.61	1.11	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	197.97	110.01	34.46	5.14	1.81	1.51	0.91	1.81	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	245.47	82.10	99.58	5.47	5.30	2.32	1.33	0.91	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	285.83	94.36	102.57	8.55	7.86	2.22	2.22	1.88	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	146.15	64.37	21.35	4.60	4.27	0.66	0.66	1.31	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	169.90	95.55	74.67	13.85	10.44	1.70	1.07	1.17	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	195.50	97.83	54.48	13.83	5.90	1.69	0.17	0.17	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	179.87	66.65	41.87	10.04	9.57	6.12	2.04	2.67	3.14
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	421.04	576.15	110.80	221.60	44.32	44.32	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	76.69	39.22	53.16	5.23	3.49	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	64.14	73.85	31.03	6.07	2.25	1.04	0.35	0.35	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	104.36	119.45	40.34	8.85	2.60	1.30	0.26	0.78	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	82.53	104.76	37.30	9.71	1.53	0.26	0.77	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	28.33	58.95	23.73	5.36	0.00	1.53	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	30.63	83.59	21.69	9.57	0.64	1.28	1.28	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	17.69	94.42	36.80	11.41	0.00	0.57	1.14	0.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	13.79	57.36	47.71	6.89	0.28	0.55	1.65	0.55	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	15.30	56.17	39.50	4.34	0.23	0.46	1.14	0.68	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	20.41	64.79	41.21	11.49	0.20	0.79	0.59	0.79	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	17.71	58.42	47.32	4.49	0.00	0.26	2.11	0.00	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	18.26	56.42	41.75	1.96	0.33	0.33	1.96	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	18.57	95.96	34.94	9.73	0.00	1.33	0.00	0.88	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	24.02	54.97	33.63	10.60	0.14	0.85	0.42	0.85	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	24.87	58.00	41.75	8.13	0.62	2.22	0.62	0.86	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	16.39	81.66	25.52	10.48	0.27	2.42	0.54	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	42.12	35.06	32.71	6.07	0.12	0.87	0.50	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	39.04	33.91	35.16	8.31	0.00	0.97	0.83	0.69	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	26.84	54.08	24.80	3.46	0.00	0.81	1.22	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	41.30	46.09	35.14	6.85	1.37	0.46	1.14	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	46.96	43.35	37.87	5.85	0.62	1.25	0.75	1.12	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	46.12	42.19	36.50	5.90	0.87	0.44	0.66	1.09	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	39.89	42.55	40.19	4.14	0.59	1.18	1.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	45.14	36.72	37.04	3.97	1.11	1.75	1.11	0.79	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	33.29	39.99	30.39	4.69	0.89	0.22	0.22	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	33.27	38.71	33.07	3.23	0.40	0.60	1.61	0.40	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	41.90	41.22	38.51	5.94	0.85	1.19	0.85	0.51	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	57.73	85.66	47.97	7.45	1.68	0.44	1.42	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	64.20	81.37	56.09	6.66	1.25	0.10	1.14	0.00	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	53.97	69.68	49.53	5.98	0.85	0.85	0.17	0.00	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	50.79	34.97	42.27	3.98	0.44	0.89	1.00	0.55	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	53.08	74.29	48.34	5.66	2.25	0.33	0.42	0.08	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.96	66.77	39.00	7.96	1.84	0.00	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	46.63	40.02	36.31	1.86	0.62	1.24	0.62	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	57.88	32.05	50.38	2.65	1.04	0.92	1.27	0.58	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	41.52	43.03	35.35	5.17	0.67	1.00	1.50	0.50	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	43.87	37.69	41.88	2.65	0.88	1.54	0.88	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	59.28	36.04	47.97	3.69	1.35	1.97	1.23	1.48	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	46.20	41.17	33.72	1.78	1.46	0.97	0.81	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	58.69	48.43	47.79	2.89	1.60	1.92	0.32	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	51.93	28.52	47.19	3.41	0.85	1.14	0.66	0.66	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	43.81	39.54	36.22	4.43	0.63	0.63	0.95	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	42.57	50.17	35.88	4.87	1.22	1.52	1.22	0.00	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	54.15	31.36	41.50	3.14	1.05	1.05	0.42	0.73	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	48.74	40.62	45.01	2.85	0.88	0.66	0.88	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.44	32.82	30.30	3.65	0.84	0.56	0.28	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	63.51	31.02	37.59	4.26	0.74	1.20	0.56	0.56	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	47.60	59.10	33.96	4.55	1.87	0.80	0.80	1.07	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	48.66	43.45	33.20	4.90	1.38	1.22	0.31	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	65.68	29.53	36.66	4.02	1.30	0.78	0.13	0.39	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	67.77	48.79	36.59	4.61	1.63	1.36	0.27	1.08	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	81.67	45.72	42.22	2.58	0.74	3.50	0.74	0.92	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	86.41	49.13	51.10	1.97	1.97	3.29	1.32	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	111.08	55.54	68.43	1.98	0.99	3.97	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	105.13	46.57	44.72	2.90	3.03	1.58	0.79	1.06	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	97.05	38.54	43.98	2.82	2.42	1.41	2.22	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	165.97	106.75	127.08	3.56	10.17	0.76	0.51	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	18.51	120.43	43.79	17.92	0.20	0.60	1.19	0.40	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	13.87	56.85	37.44	8.94	0.15	0.46	0.62	0.62	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	18.82	67.31	35.39	10.02	0.00	1.84	0.00	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	26.60	78.23	31.61	8.76	0.00	0.31	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	24.86	72.90	27.41	6.50	0.00	0.00	0.57	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	21.22	59.96	39.66	6.46	0.46	2.31	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	84.14	37.12	7.42	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	26.69	85.48	28.62	8.90	0.00	1.93	1.93	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	20.86	96.27	24.07	4.81	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	29.56	78.25	46.95	10.43	1.74	1.74	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	27.01	63.14	28.64	4.88	0.98	0.00	0.98	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	33.36	67.12	28.00	3.29	0.41	0.82	1.24	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	39.99	33.32	13.33	0.00	13.33	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.36	64.60	31.04	6.71	0.56	0.84	1.40	0.56	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	37.59	80.40	27.13	8.50	0.98	0.65	0.98	0.00	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	37.75	39.43	46.14	5.87	0.00	7.55	1.68	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	39.44	59.80	36.90	8.59	0.32	1.91	1.91	0.95	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	38.38	55.70	31.93	8.15	0.68	0.34	2.38	1.02	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	39.67	33.41	0.00	0.00	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	40.09	51.54	47.53	3.44	0.57	1.15	1.72	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	44.99	49.43	33.15	7.70	0.59	0.89	1.78	0.59	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	28.80	59.30	28.80	1.69	0.00	1.69	0.00	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	47.22	79.11	30.65	7.46	1.66	1.66	2.49	0.41	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.91	74.79	34.52	7.82	1.61	1.61	2.07	0.92	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	15.81	10.54	10.54	0.00	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	39.59	68.43	34.98	5.00	0.77	1.54	0.77	0.38	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	49.55	64.22	39.44	5.87	0.98	1.30	0.65	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	49.49	30.10	40.13	4.68	0.67	2.01	0.67	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	60.87	53.17	43.15	2.70	1.16	1.54	1.16	1.54	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	68.81	70.18	47.24	5.82	1.71	2.05	2.40	1.37	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	44.73	49.70	0.00	7.45	9.94	4.97	2.48	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	50.96	39.64	46.71	3.77	1.42	0.94	0.94	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	56.73	42.24	51.90	4.83	1.21	3.62	1.81	1.81	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	57.99	43.24	56.46	3.56	0.51	0.00	1.53	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	55.44	51.85	49.85	5.18	0.40	1.60	1.99	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	75.98	43.42	50.82	4.44	2.47	0.00	0.00	0.99	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	81.45	30.69	54.30	3.54	5.90	0.00	0.00	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	51.34	35.01	41.42	5.25	1.17	0.58	2.33	0.58	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	96.12	50.91	56.18	7.02	3.51	3.51	1.32	0.44	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	44.08	37.30	38.15	2.54	1.70	0.85	0.85	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	34.62	45.96	37.01	0.60	1.79	1.19	0.00	0.60	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	41.25	45.13	32.03	1.94	2.91	0.97	1.94	1.46	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	175.76	42.23	36.52	7.99	5.71	0.00	1.14	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	168.82	46.16	47.82	5.41	6.24	2.91	2.91	2.08	2.91
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	104.57	58.47	16.87	3.37	4.50	1.12	1.12	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	136.06	49.48	44.72	2.22	7.29	1.90	0.95	0.63	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	112.37	45.12	38.43	3.34	6.68	0.84	0.42	1.67	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	43.28	100.26	20.08	11.72	4.99	1.74	0.93	0.58	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	45.07	108.37	18.91	9.62	4.39	1.18	0.68	0.68	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	48.46	87.36	20.02	6.37	3.87	1.82	0.46	0.00	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	44.49	94.33	20.66	9.95	4.26	2.40	0.33	0.77	1.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	49.43	98.21	16.98	9.24	2.58	1.50	0.64	0.43	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	49.95	87.40	20.88	8.83	3.23	1.29	0.22	0.65	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	49.07	88.30	21.54	8.84	4.61	1.49	0.87	0.25	1.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	45.63	88.18	18.53	8.06	3.77	1.37	0.69	0.34	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	50.62	58.95	18.26	8.65	3.84	1.60	0.96	0.32	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	35.26	26.86	22.94	5.04	0.00	0.56	0.00	0.56	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	57.56	18.18	12.12	2.60	0.87	0.43	0.87	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	74.03	13.22	0.00	7.93	5.29	0.00	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	131.21	59.61	34.57	5.64	3.88	0.35	0.71	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	104.62	32.69	21.07	1.45	0.73	0.00	0.00	0.00	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	99.13	73.78	19.23	4.55	4.37	2.80	1.22	0.87	0.52
Hepatocyte, donor1	11523-119I2	121.06	93.22	47.21	1.21	30.27	4.84	3.63	2.42	1.21
Hepatocyte, donor2	11603-120I1	180.99	43.09	28.01	4.31	4.31	0.00	3.23	1.08	1.08
Hepatocyte, donor3	11684-122I1	102.46	58.90	48.47	2.45	9.20	1.84	0.00	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	28.07	28.07	5.22	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	29.36	123.92	18.88	4.02	3.32	1.05	0.52	0.52	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	88.64	75.19	45.14	5.63	3.70	1.65	0.82	0.55	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	28.66	6.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	46.73	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	23.53	2.77	4.15	0.00	0.00	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	20.02	5.01	7.51	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	59.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	38.44	0.00	5.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	13.71	4.57	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	21.12	6.50	4.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	36.68	5.00	3.33	0.00	1.67	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	10.89	10.89	7.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	26.47	5.29	3.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	1.11	24.39	7.76	1.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	36.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.78	27.71	1.89	5.04	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	30.93	1.55	3.09	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	29.27	29.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.81	29.72	3.88	3.88	0.65	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	27.37	3.22	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	35.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	7.33	28.52	2.44	4.07	0.00	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.20	50.80	4.20	5.46	0.00	0.00	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.04	27.33	3.21	1.61	0.00	0.80	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2.77	24.93	1.85	3.69	0.00	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	30.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	5.19	26.43	4.25	9.44	0.00	0.00	0.47	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	25.40	1.81	4.53	0.00	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	2.15	31.21	4.30	3.23	0.00	0.00	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	25.41	1.27	6.35	0.00	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	0.00	16.43	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2.55	28.06	1.91	1.91	0.00	0.64	0.64	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	30.99	3.65	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.00	26.42	5.71	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	9.95	6.64	9.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.25	27.78	5.56	4.94	0.00	0.93	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	29.85	0.00	5.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	18.86	6.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.09	25.73	2.09	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	11.07	6.64	4.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	29.18	6.48	9.73	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	10.46	20.05	10.46	3.49	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	9.00	6.75	4.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	5.33	26.67	9.60	2.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	26.32	4.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	31.35	2.85	2.85	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	2.76	20.25	2.76	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	15.13	6.05	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	12.42	12.42	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	5.29	15.86	9.52	4.23	0.00	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	60.06	125.74	50.43	7.02	2.53	0.65	0.98	0.24	0.16
Keratinocyte - epidermal, donor2	11349-117G8	42.17	53.88	26.94	5.86	0.00	0.59	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	57.27	42.12	34.83	5.96	0.28	1.33	0.38	0.57	0.76
Keratinocyte - oral, donor1	11251-116E9	90.59	134.86	92.97	11.69	1.25	2.72	0.45	0.91	0.91
Keratocytes, donor1	11527-119I6	91.80	29.57	52.26	9.28	1.03	1.38	1.03	0.00	0.34
Keratocytes, donor2	11607-120I5	75.00	17.58	19.92	3.52	2.34	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	99.39	20.55	34.97	1.78	2.17	1.38	0.40	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	37.36	17.58	0.00	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	51.78	44.23	35.60	2.16	1.08	0.00	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	53.05	40.37	78.77	3.92	1.50	0.92	0.23	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	169.02	47.53	50.96	4.34	9.59	0.71	0.50	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	63.08	78.38	30.71	6.88	2.13	1.19	0.83	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	37.68	40.74	16.74	3.35	0.84	1.95	1.40	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	60.60	59.19	24.24	4.56	1.26	0.94	0.63	0.47	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	39.25	35.49	15.59	2.69	1.61	0.00	1.08	0.00	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	47.27	52.95	16.39	4.73	0.95	1.26	0.63	0.63	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	43.77	49.38	16.60	2.91	1.08	1.40	0.65	0.75	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	40.63	43.91	20.11	6.57	1.23	1.23	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	30.59	41.97	13.40	3.03	0.25	0.76	0.00	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	41.38	53.77	16.61	3.80	1.55	1.13	0.99	0.42	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	28.08	47.86	15.82	2.77	0.40	0.79	0.40	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	42.07	49.83	16.48	3.49	0.78	0.19	0.19	0.78	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	30.18	29.07	10.37	2.04	0.93	0.93	0.19	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	39.72	41.46	12.19	4.88	1.05	0.00	0.35	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	39.59	52.00	16.94	5.72	1.19	0.95	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	38.87	43.54	16.07	3.85	0.96	1.37	0.14	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	40.96	44.65	16.32	2.46	0.31	1.85	0.62	0.62	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	30.86	41.46	14.03	4.05	0.62	0.94	0.94	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	45.93	55.08	19.58	5.49	1.65	0.18	0.37	0.37	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	37.19	39.82	16.46	4.61	0.66	1.97	0.33	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	38.66	54.18	10.84	2.34	0.00	0.29	2.05	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	33.36	43.81	10.46	3.73	0.50	0.25	0.50	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	33.95	44.62	17.94	3.39	0.97	0.97	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	41.47	41.74	11.85	3.77	0.54	0.54	0.81	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	45.56	47.08	14.08	2.12	0.61	1.06	1.06	0.76	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	29.55	47.69	15.03	3.63	0.52	0.00	0.52	0.52	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	43.13	47.95	17.17	3.35	0.21	1.47	1.68	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	50.07	43.91	14.74	4.06	0.60	0.90	0.60	0.75	1.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	44.02	41.27	15.82	2.06	0.69	0.00	2.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	37.25	49.29	14.11	2.63	0.56	0.56	0.94	0.94	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	44.53	46.44	15.59	3.29	0.64	0.74	0.85	0.74	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	42.16	38.28	14.05	2.91	0.48	0.97	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	33.74	45.65	12.24	3.64	0.00	0.33	0.00	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	42.12	46.95	18.09	3.59	0.99	1.12	0.99	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	47.76	48.13	20.36	4.81	0.74	1.11	0.37	0.00	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	34.59	49.42	12.85	5.44	0.00	0.49	0.74	0.25	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	43.04	43.45	12.92	2.61	0.82	0.69	0.41	0.55	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	42.46	48.57	19.62	4.82	0.64	1.29	0.00	0.64	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	41.08	56.61	12.78	2.13	0.00	0.61	0.61	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	46.61	50.11	19.04	2.66	0.98	0.84	1.12	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	36.62	45.16	12.09	2.84	0.71	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	33.45	45.57	9.21	2.42	0.48	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	39.21	42.01	11.98	2.96	0.78	1.09	0.31	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	45.84	32.23	12.53	2.51	0.36	0.36	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	43.12	45.08	13.39	2.94	0.00	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	33.43	33.19	8.95	2.12	1.41	0.47	0.71	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	53.58	86.87	21.90	5.45	0.99	0.74	0.62	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	31.50	34.83	9.22	2.05	0.00	0.51	0.51	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	39.98	35.21	11.93	1.79	0.30	0.60	0.30	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	56.65	22.66	4.53	4.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	35.29	56.00	29.92	4.60	4.60	1.53	0.77	0.77	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	27.46	62.35	13.36	4.45	7.42	0.74	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	34.27	77.01	24.54	5.08	4.23	0.85	2.54	0.00	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	28.13	56.97	23.91	4.22	4.92	1.41	0.00	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	27.09	57.91	23.35	6.54	2.80	0.93	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	29.37	70.59	19.58	5.67	3.09	3.09	1.55	3.09	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	20.22	54.72	15.46	3.57	2.38	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	28.95	90.93	22.62	4.52	5.43	0.68	0.45	0.00	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	31.70	70.09	19.78	4.65	2.62	2.04	0.29	0.58	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.51	63.02	29.26	4.05	3.15	2.25	0.00	2.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	40.51	118.41	31.43	6.37	6.23	1.08	0.41	0.54	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	31.32	74.46	20.54	5.14	5.14	2.57	1.03	1.54	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	32.82	62.10	24.35	4.23	3.53	1.06	1.41	1.41	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	31.98	41.31	23.99	2.67	3.33	2.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	36.68	79.46	20.88	4.08	6.62	4.08	4.58	0.51	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	29.62	76.57	26.41	3.74	7.20	1.33	0.53	0.53	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	37.03	78.22	24.37	4.72	3.02	2.65	0.76	0.94	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	28.84	71.79	23.32	4.91	6.75	0.61	4.91	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	50.56	83.99	33.43	2.45	2.45	1.63	0.00	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	40.61	83.30	28.53	4.16	4.37	2.50	1.46	1.04	1.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	38.12	90.52	23.54	3.92	3.08	3.64	3.08	0.56	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	40.18	88.61	22.67	2.06	6.18	5.15	3.09	4.12	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	39.48	72.00	26.71	4.94	5.23	4.35	2.90	2.61	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	32.58	74.73	21.52	6.88	4.19	1.49	0.60	0.30	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	37.07	58.65	20.47	1.11	1.66	2.21	0.55	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	39.59	92.26	23.68	2.47	9.54	2.83	2.12	2.12	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	35.03	84.82	24.34	6.27	3.69	4.79	1.48	1.11	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	24.18	55.26	17.27	4.61	1.15	0.00	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	39.14	85.96	25.33	2.30	2.30	0.38	1.15	0.77	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	34.53	92.85	16.98	3.96	3.40	7.36	0.57	1.70	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	34.46	66.46	16.41	4.92	0.00	1.64	0.82	0.82	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	37.96	91.73	21.24	6.33	4.07	2.26	1.36	0.90	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	30.16	89.77	21.54	4.31	3.59	2.15	1.44	0.00	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	25.39	64.23	31.37	3.73	5.23	0.00	0.00	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	43.10	97.73	29.73	4.83	4.46	4.46	1.49	1.86	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	35.32	85.29	26.28	5.17	4.31	1.72	0.00	1.29	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	35.96	79.64	28.26	7.71	1.71	0.86	0.00	3.43	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	46.98	88.63	26.32	6.66	3.33	3.66	1.00	1.00	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	42.83	92.31	27.15	1.81	2.41	2.41	1.21	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	41.24	61.15	12.80	5.69	3.55	2.84	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	39.53	85.24	29.90	6.19	5.50	4.12	0.69	0.69	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	31.13	91.25	20.93	3.22	3.22	4.29	1.07	1.07	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	30.97	69.36	22.22	4.71	6.73	0.00	1.35	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	39.26	95.19	27.41	4.44	4.44	3.33	1.11	1.11	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	34.89	77.92	24.42	2.33	5.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	30.67	56.06	17.98	6.35	1.06	1.06	0.00	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	47.62	90.83	22.41	6.40	4.40	3.60	1.20	1.20	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.26	77.78	18.17	4.36	5.09	1.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	45.99	59.02	33.73	6.13	2.30	1.53	0.00	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	35.02	80.40	27.62	5.43	4.93	1.97	1.48	0.99	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	26.35	78.10	16.94	0.94	2.82	1.88	0.94	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	38.72	81.96	25.14	8.55	3.02	0.50	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	41.91	93.73	21.63	6.76	5.41	1.35	0.90	1.80	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	25.82	92.94	15.49	3.44	1.72	3.44	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	36.52	80.16	26.72	3.12	3.12	2.23	0.45	1.78	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	43.79	83.29	22.29	2.74	3.91	2.35	1.56	1.96	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	27.05	77.85	11.22	1.98	4.62	2.64	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	36.84	85.62	21.79	6.75	4.15	0.52	0.00	0.52	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	38.51	92.76	31.50	6.13	1.75	4.38	2.19	1.75	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	39.14	90.57	21.80	3.35	5.59	1.12	0.56	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	34.45	69.34	25.17	2.21	4.86	3.09	0.44	1.32	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	40.50	70.97	25.46	5.40	2.70	3.09	0.39	1.16	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	31.39	89.62	16.71	2.03	2.53	4.56	1.01	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	40.85	66.81	19.22	3.84	3.36	0.00	0.00	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	41.74	78.71	21.87	7.95	3.98	1.59	2.39	0.00	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	32.81	80.81	20.05	1.82	2.43	0.61	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	25.59	64.33	15.22	2.77	3.46	0.69	0.69	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	51.68	81.70	23.18	5.70	3.42	2.66	0.38	1.52	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	38.21	91.92	19.62	4.13	5.16	2.58	0.52	1.55	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	35.07	66.51	21.77	2.42	0.60	1.81	0.00	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	46.27	78.27	20.60	6.34	3.17	3.80	1.58	0.95	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	37.32	81.03	20.79	4.80	0.53	0.00	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	22.99	68.96	19.54	8.05	2.87	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	41.14	79.71	18.00	6.17	2.57	3.60	1.03	2.06	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	40.32	94.79	19.10	4.24	2.12	2.12	2.12	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	28.94	73.21	18.16	5.11	1.70	1.13	0.57	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	42.43	70.72	17.89	3.33	4.99	2.50	0.83	0.83	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	33.67	84.57	18.01	3.13	3.92	1.57	0.78	1.57	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	28.81	73.07	17.54	5.85	3.76	0.42	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	41.35	85.96	22.77	4.18	3.72	1.86	0.93	1.39	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	29.44	76.27	18.06	3.35	4.01	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	39.56	93.56	25.66	4.81	5.88	0.00	0.53	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	39.20	79.61	20.61	4.45	4.04	2.83	0.81	1.21	2.83
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	29.37	78.93	13.77	0.92	3.67	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	30.23	67.57	21.34	6.22	2.67	2.67	0.00	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	47.87	76.93	17.67	5.70	1.71	1.14	0.57	1.14	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	42.18	72.09	18.41	6.90	5.37	2.30	0.77	0.77	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	39.40	98.49	21.34	3.83	3.28	1.09	1.64	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	41.43	90.43	20.05	7.57	2.67	0.89	0.89	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	53.03	134.40	36.91	7.02	4.42	0.78	0.78	0.26	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	44.43	90.85	23.21	5.30	4.64	1.99	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	122.64	20.79	8.31	0.00	0.00	2.08	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	26.67	53.10	34.64	3.19	2.51	0.68	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	18.90	88.27	35.60	4.59	9.91	0.55	0.37	0.55	0.37
Macrophage - monocyte derived, donor3	11389-118C3	21.76	48.11	40.77	3.93	3.41	1.18	0.52	0.79	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	41.95	67.97	17.52	5.31	3.19	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	93.01	115.04	33.91	11.09	5.70	1.58	1.90	0.48	0.16
Mallassez-derived cells, donor3	11930-125I4	90.34	107.16	31.69	11.67	1.53	1.39	0.97	0.28	0.56
Mammary Epithelial Cell, donor1	11273-116H4	86.59	123.46	56.70	13.65	1.69	0.90	0.60	0.90	0.40
Mammary Epithelial Cell, donor2	11350-117G9	62.54	116.40	34.46	13.90	1.16	0.29	0.00	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	67.10	52.63	21.95	6.98	0.50	1.00	1.00	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	288.80	157.96	37.29	6.10	25.08	0.00	2.71	1.36	0.00
Mast cell, donor1	11563-120D6	45.74	82.19	25.20	2.38	5.84	0.22	0.65	0.32	0.11
Mast cell, donor2	11565-120D8	41.31	41.90	25.56	0.59	8.92	0.00	2.38	0.30	0.00
Mast cell, donor3	11566-120D9	49.53	53.80	33.77	4.95	13.73	0.00	2.03	0.00	0.23
Mast cell, donor4	11567-120E1	43.44	43.44	33.33	1.95	10.46	0.35	1.77	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	33.71	128.08	21.74	7.65	13.53	1.11	0.44	0.67	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	70.04	145.34	14.59	1.75	15.18	2.33	1.17	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	31.09	77.55	20.42	3.79	8.72	0.69	1.84	0.00	0.57
Mast cell, expanded, donor8	11941-126A6	42.18	119.50	17.24	4.52	7.03	1.00	1.84	0.33	0.17
Melanocyte - dark, donor1	11502-119F8	78.60	66.76	33.83	7.06	1.29	0.70	0.60	0.30	0.10
Melanocyte - dark, donor2	11582-120F7	91.37	65.76	24.92	6.23	3.11	2.08	1.38	0.69	1.38
Melanocyte - dark, donor3	11663-122F7	39.26	84.47	52.88	11.16	1.38	0.43	0.00	0.36	0.07
Melanocyte - light, donor1	11274-116H5	36.44	55.24	36.67	9.64	2.12	0.00	2.59	0.71	0.00
Melanocyte - light, donor2	11351-117H1	35.49	49.14	33.44	5.46	0.68	0.68	0.00	1.36	0.68
Melanocyte - light, donor3	11423-118G1	28.62	29.49	20.81	0.87	1.73	0.87	0.00	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	42.07	44.98	38.63	5.94	1.04	1.87	0.94	0.31	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	42.22	59.71	33.35	8.07	1.34	0.81	0.81	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	39.37	50.89	47.68	8.04	1.34	1.34	1.34	0.54	0.54
Meningeal Cells, donor1	11493-119E8	144.90	105.08	30.77	16.62	4.22	0.12	0.25	0.12	0.00
Meningeal Cells, donor2	11573-120E7	132.48	72.18	47.10	14.08	3.08	2.64	0.44	0.44	0.44
Meningeal Cells, donor3	11654-122E7	102.04	136.92	25.18	8.97	5.05	1.06	0.33	0.49	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	115.77	81.27	38.50	16.82	4.85	0.57	1.71	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	213.04	73.96	66.12	5.84	16.40	1.31	0.70	0.40	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	65.71	26.28	10.51	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	51.02	26.16	3.92	1.31	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	86.11	57.41	22.25	1.44	5.74	0.72	2.15	2.87	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	135.11	65.01	36.42	6.35	5.08	1.48	0.64	1.06	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	108.57	62.33	26.64	6.53	5.03	2.51	1.01	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	79.77	69.00	19.34	7.03	3.30	0.44	0.44	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	79.63	46.76	15.34	10.23	0.73	0.00	1.46	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	64.25	36.83	13.71	4.91	3.07	1.23	1.02	0.41	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	167.73	90.86	59.97	7.34	9.14	1.11	1.52	0.55	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	59.85	37.17	18.96	1.49	4.09	0.37	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	170.65	124.21	53.68	5.79	6.05	1.18	0.79	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	194.96	32.34	16.02	1.78	7.42	2.97	0.30	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	121.45	32.70	23.36	4.67	4.67	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	146.01	51.87	23.69	8.33	3.84	1.92	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	127.60	109.88	25.52	9.22	9.92	0.00	1.06	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	182.01	101.64	50.04	5.32	8.13	0.31	1.25	1.25	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	91.44	63.86	25.40	12.34	3.63	2.90	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	90.96	62.85	58.07	6.10	5.83	1.59	2.92	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	67.06	34.03	54.05	4.00	3.00	1.00	0.50	0.50	1.50
Mesothelial Cells, donor3	11402-118D7	50.95	54.56	51.74	3.40	1.88	2.10	0.87	1.23	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	40.51	51.31	25.66	2.70	4.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	39.16	49.99	35.46	6.16	2.46	0.49	0.49	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	30.03	51.53	37.69	6.48	7.07	0.00	0.29	0.88	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	51.86	17.29	41.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	29.13	37.81	26.04	2.79	2.17	0.31	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	20.54	52.48	24.06	5.60	3.94	1.04	0.21	0.41	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	16.21	25.48	0.00	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	32.53	40.29	34.04	3.25	3.75	0.00	1.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	30.26	69.82	45.15	4.65	9.78	0.47	0.00	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	25.20	35.97	30.89	3.45	3.86	1.02	0.41	1.22	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.93	58.60	31.68	3.56	7.52	0.40	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	25.65	51.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	10.62	42.48	25.66	2.65	4.42	3.54	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	22.04	61.93	35.33	5.32	6.84	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	27.63	13.16	30.27	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	24.62	45.84	25.47	2.33	2.33	0.42	0.42	1.06	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	17.50	30.39	24.86	1.84	3.68	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	20.86	37.85	22.65	3.28	1.79	0.89	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	33.53	10.06	31.86	0.00	8.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	101.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	21.58	40.14	16.81	2.51	3.51	1.00	0.25	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	20.44	41.83	25.19	1.66	3.80	1.43	0.71	0.48	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	28.75	27.09	24.33	1.11	2.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.56	43.29	17.04	2.99	3.68	0.23	0.23	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	32.81	49.22	30.92	4.42	5.47	0.84	0.21	0.63	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	20.99	34.65	8.97	2.65	2.65	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	16.52	35.83	18.24	5.36	3.22	0.00	0.43	0.64	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	26.01	40.46	30.01	4.89	4.89	0.67	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	51.59	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	23.87	31.32	19.49	2.63	3.07	0.22	0.44	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	14.19	27.38	30.92	2.03	9.13	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	33.14	16.57	16.57	1.66	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.10	32.07	23.65	1.36	2.99	0.27	0.54	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	25.59	49.11	30.58	3.23	7.35	0.00	0.59	0.59	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	14.17	25.08	28.35	0.00	2.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	21.62	32.68	22.11	2.40	2.40	0.48	0.00	0.96	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	21.21	44.03	22.81	2.40	2.80	1.20	0.00	1.20	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	31.54	16.45	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	15.52	37.04	19.02	2.00	2.50	1.50	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	12.23	12.23	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	16.20	27.15	9.63	4.82	2.19	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	25.38	28.69	27.59	2.21	6.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	22.41	28.18	10.25	0.00	1.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	18.59	38.68	14.13	2.23	2.98	0.50	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	18.09	26.44	21.57	2.09	1.39	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	15.47	17.68	0.00	2.21	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	8.55	39.66	10.94	2.39	0.68	0.00	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.88	31.95	24.51	3.94	2.19	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.52	25.92	8.52	1.42	0.71	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.10	35.91	10.10	2.24	1.40	0.56	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	10.81	32.42	17.87	3.33	2.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.91	20.40	6.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.24	31.67	9.65	2.71	0.30	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.51	39.23	15.86	2.92	1.67	0.83	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	28.88	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	7.39	24.94	14.78	1.85	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5.69	46.10	11.38	2.28	2.28	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.29	31.92	7.88	2.76	0.14	0.00	0.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.66	31.10	9.07	1.81	1.04	0.52	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.30	30.03	17.16	1.72	0.43	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.72	14.61	4.45	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	3.74	22.69	11.21	0.53	0.00	0.27	0.00	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	18.26	36.82	20.95	2.69	1.20	0.00	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.04	23.31	7.35	0.57	0.14	0.00	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.78	23.89	10.19	2.87	0.96	0.00	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	11.72	42.01	11.94	1.77	0.88	0.22	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.58	24.27	7.96	1.90	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	7.67	26.14	11.08	1.42	1.42	0.57	0.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.08	45.23	11.55	4.67	0.74	0.49	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.73	26.07	13.69	0.00	1.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.70	29.11	15.29	1.47	0.59	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.72	38.92	17.30	4.04	1.44	0.00	0.29	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.96	65.94	19.37	1.65	0.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.59	22.63	14.29	1.49	0.89	0.00	0.00	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	41.44	11.30	3.77	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	37.43	23.17	5.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	21.03	53.23	28.59	0.00	0.99	2.63	0.66	1.31	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	41.03	22.09	1.05	1.05	2.10	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	15.62	53.97	15.42	2.17	1.58	0.40	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	23.28	48.43	26.08	1.86	3.73	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.77	57.83	26.66	3.38	1.50	1.88	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	15.98	37.29	27.43	4.26	2.66	0.53	0.00	0.27	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.36	45.01	14.02	2.60	0.90	0.34	0.23	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	19.15	40.52	19.89	4.42	2.95	0.00	2.95	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	21.62	47.64	26.38	1.10	1.47	1.47	0.37	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	43.56	14.00	3.11	1.56	1.56	0.00	6.22	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	13.90	41.69	12.83	2.14	0.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	15.46	42.50	0.00	3.86	0.00	0.00	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	24.24	56.56	36.36	3.03	2.02	3.03	2.02	1.01	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	16.87	32.47	25.30	2.95	2.95	0.84	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	19.07	8.17	0.00	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	8.90	3.81	0.64	1.91	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	14.58	6.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	12.08	36.25	3.02	4.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	119.91	22.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	110.92	29.36	3.26	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	57.03	9.50	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	87.84	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	172.35	82.73	35.12	10.13	7.54	1.51	0.43	0.86	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	146.33	50.69	42.33	5.75	2.09	3.14	0.52	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	95.45	48.73	36.71	3.34	4.67	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	98.50	32.14	40.90	4.17	1.25	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	117.89	70.54	31.18	14.26	3.80	1.33	0.19	0.76	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	175.54	54.26	111.71	1.60	0.00	0.00	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	58.48	34.00	50.32	2.04	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	88.21	73.51	11.03	9.19	0.00	5.51	0.00	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	83.29	37.25	35.58	1.67	2.93	0.84	0.42	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	111.57	50.90	40.91	4.88	2.09	1.39	0.46	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	111.87	34.86	45.67	3.51	3.51	0.54	0.54	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	111.00	46.67	42.89	5.68	2.73	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	278.37	167.02	33.40	11.13	33.40	11.13	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	83.88	67.01	32.26	6.45	4.47	0.50	0.50	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	135.06	41.41	52.24	4.33	4.06	1.08	0.81	1.08	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	107.22	45.79	40.35	4.53	3.85	1.36	0.45	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	116.92	34.78	45.07	2.29	3.43	0.98	0.16	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	116.46	51.94	55.22	6.38	4.92	1.82	0.91	0.00	2.19
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	93.36	49.33	48.27	5.30	1.59	0.53	2.12	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	106.85	55.23	38.42	4.20	0.60	0.60	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	114.86	73.51	33.80	7.22	6.24	1.31	2.30	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	107.17	35.94	47.16	3.90	3.42	0.65	0.16	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	132.82	50.27	57.15	3.35	2.65	0.88	0.53	0.00	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	90.01	42.19	55.56	3.52	3.52	0.70	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	119.06	45.05	57.00	2.30	0.92	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	132.39	31.49	77.12	1.93	3.21	0.32	0.32	0.64	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	155.54	65.18	39.32	7.93	6.90	4.14	1.72	1.72	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	199.75	88.50	58.15	5.06	2.53	12.64	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	121.19	36.31	62.83	2.23	3.34	0.45	0.45	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	98.65	36.41	66.90	3.39	2.12	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	96.60	47.95	39.40	3.80	3.56	0.24	0.00	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	153.24	40.78	98.73	5.15	5.15	0.86	1.29	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	352.08	135.42	126.39	27.08	36.11	9.03	0.00	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	174.94	33.66	90.97	2.00	4.00	1.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	126.24	27.50	71.69	1.80	5.86	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	87.69	32.54	58.33	1.98	5.56	0.00	1.19	0.00	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	101.22	36.22	45.50	2.79	2.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	160.43	37.84	86.65	4.16	5.68	4.54	1.14	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	125.79	33.89	64.20	3.26	4.89	1.30	0.33	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	139.45	17.00	113.74	1.31	2.18	0.00	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	169.16	37.99	96.79	1.36	4.07	0.45	0.45	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	95.25	35.28	69.67	4.41	5.29	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	85.77	42.55	50.53	2.66	5.98	1.99	0.00	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	149.31	32.74	97.22	0.99	4.46	1.49	1.98	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	139.35	29.09	101.45	3.45	8.04	0.77	0.38	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	159.09	31.15	78.94	3.33	5.75	0.60	0.30	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	138.36	37.35	68.74	3.32	6.19	1.11	1.77	0.22	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	87.42	40.66	65.73	2.03	2.03	0.68	4.07	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	91.97	30.66	45.99	10.22	5.11	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	148.76	29.87	127.42	3.05	3.05	1.22	0.00	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	167.44	25.49	98.83	2.83	8.18	0.00	0.31	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	121.36	28.15	91.10	2.12	1.82	1.21	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	153.48	34.02	105.22	3.16	5.54	0.79	1.58	0.00	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	133.77	46.48	46.48	5.67	3.40	4.53	0.00	0.00	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	91.04	40.46	5.06	10.12	15.17	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	147.46	99.38	33.91	6.58	16.65	2.11	0.87	0.75	1.24
Myoblast, donor2	11322-117D8	126.39	69.04	44.49	5.95	6.52	3.26	1.92	2.49	1.15
Myoblast, donor3	11398-118D3	98.38	86.27	54.48	12.61	8.07	0.84	0.34	0.84	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	26.41	33.27	1.46	0.00	0.73	0.29	0.44	0.29
Natural Killer Cells, donor1	11230-116C6	6.46	27.37	22.14	0.62	0.92	0.31	0.62	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	3.62	15.98	16.28	0.30	0.60	0.00	0.30	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	4.42	20.43	18.59	0.55	0.74	0.55	0.00	0.18	0.18
Neural stem cells, donor1	11275-116H6	43.55	139.37	70.77	3.63	5.08	1.09	3.99	0.36	0.00
Neural stem cells, donor2	11352-117H2	48.14	78.95	90.51	5.78	0.00	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	15.93	47.79	39.83	2.28	1.14	1.14	0.00	0.00	0.00
Neurons, donor2	11574-120E8	11.45	55.70	56.14	1.54	0.22	0.22	0.22	0.22	0.44
Neurons, donor3	11655-122E8	19.73	37.00	32.89	0.82	0.00	0.82	0.82	0.82	0.00
Neutrophils, donor1	11233-116C9	0.93	90.94	5.57	0.00	0.00	2.78	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	98.56	2.90	0.00	0.00	0.00	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	3.67	166.76	2.44	2.44	0.00	0.00	0.61	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	198.76	107.81	68.75	3.68	6.06	2.49	0.59	0.71	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	78.14	54.70	25.07	1.95	0.98	1.63	1.30	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	85.44	29.88	36.90	3.81	1.20	0.20	0.40	0.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	151.28	69.24	37.44	4.27	3.30	1.65	1.10	0.96	0.96
Olfactory epithelial cells, donor2	11934-125I8	142.72	81.64	47.33	4.34	7.96	8.11	2.32	3.33	4.05
Olfactory epithelial cells, donor3	11935-125I9	140.97	67.42	47.79	3.75	6.92	1.93	0.91	1.36	1.25
Olfactory epithelial cells, donor4	11936-126A1	187.68	49.38	73.44	4.09	4.48	2.05	0.97	1.17	0.88
Oligodendrocyte - precursors, donor1	11496-119F2	78.84	93.88	63.79	3.61	4.81	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	290.33	118.05	85.93	9.57	15.53	0.85	1.70	0.64	0.43
Osteoblast - differentiated, donor2	11353-117H3	66.30	29.72	44.58	0.00	2.29	1.14	6.86	1.14	2.29
Osteoblast - differentiated, donor3	11425-118G3	96.83	29.79	22.97	1.86	1.86	0.62	1.86	0.00	0.00
Osteoblast, donor1	11277-116H8	216.15	96.55	40.06	8.60	7.23	2.35	0.98	0.00	0.59
Osteoblast, donor2	11354-117H4	225.44	117.99	45.65	11.24	12.64	3.51	0.00	1.40	0.00
Osteoblast, donor3	11426-118G4	253.80	83.53	50.12	7.46	6.58	2.49	0.89	0.53	0.71
Pancreatic stromal cells, donor1	11249-116E7	210.76	109.17	49.61	8.84	8.51	2.61	2.70	1.43	0.93
Pericytes, donor1	11491-119E6	46.18	18.47	22.81	3.34	1.56	0.22	0.11	0.22	0.00
Pericytes, donor2	11571-120E5	50.03	11.54	29.88	0.23	1.81	0.45	0.68	0.23	0.23
Pericytes, donor3	11652-122E5	139.97	39.67	28.89	6.31	5.29	1.83	0.41	0.20	0.61
Perineurial Cells, donor1	11499-119F5	213.27	86.12	44.87	9.04	4.52	0.57	1.02	1.02	0.57
Perineurial Cells, donor2	11579-120F4	142.52	100.02	40.39	10.31	5.98	1.20	0.74	0.28	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	7.97	67.57	23.59	2.55	1.59	0.00	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	4.65	33.79	12.24	1.47	0.98	0.73	0.24	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	7.25	28.73	23.04	0.78	0.78	0.13	0.26	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	36.35	48.55	27.50	4.07	1.91	1.20	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	76.51	27.72	32.16	6.65	7.76	2.22	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	84.62	30.63	40.64	4.91	3.73	1.37	0.59	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	136.39	48.42	31.01	5.70	6.33	2.53	2.22	2.22	0.63
Preadipocyte - breast, donor1	11467-119B9	192.84	81.79	60.22	7.50	9.75	1.50	2.06	0.19	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	330.23	169.69	15.14	10.57	9.14	1.57	0.65	0.39	0.91
Preadipocyte - breast, donor2	11328-117E5	194.75	79.48	38.28	4.73	9.01	4.73	2.25	3.60	2.25
Preadipocyte - omental, donor1	11468-119C1	184.35	87.91	65.75	8.31	10.34	1.17	1.49	0.53	0.53
Preadipocyte - omental, donor2	11329-117E6	188.99	93.84	64.16	12.22	10.48	1.75	1.31	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	200.69	75.21	64.75	5.87	7.88	4.44	1.86	2.72	1.00
Preadipocyte - perirenal, donor1	11469-119C2	130.91	39.37	57.09	7.87	8.86	0.98	1.97	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	140.66	61.73	17.81	4.30	8.60	0.31	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	177.61	125.90	26.74	8.85	10.45	7.26	2.48	1.42	2.66
Preadipocyte - subcutaneous, donor3	11428-118G6	189.53	65.90	22.99	4.43	9.88	3.75	2.72	0.68	1.36
Preadipocyte - visceral, donor1	11280-116I2	188.90	162.54	28.97	12.95	13.79	1.30	1.86	0.84	0.19
Preadipocyte - visceral, donor2	11357-117H7	141.28	97.56	23.47	5.52	10.12	6.44	5.06	1.84	2.76
Preadipocyte - visceral, donor3	11429-118G7	118.18	69.07	19.44	6.27	4.91	1.36	1.25	0.73	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	36.81	110.42	25.49	3.77	1.36	1.66	0.91	0.60	0.15
Prostate Epithelial Cells, donor2	11331-117E8	61.07	72.18	32.77	6.23	2.57	2.98	2.71	1.35	0.95
Prostate Epithelial Cells, donor3	11404-118D9	26.76	33.74	36.19	1.90	0.00	1.47	1.16	0.86	0.18
Prostate Stromal Cells, donor1	11254-116F3	171.42	139.76	45.10	9.91	9.57	2.51	1.48	1.48	0.57
Prostate Stromal Cells, donor2	11332-117E9	152.22	131.61	24.92	7.35	5.38	4.30	2.69	1.61	2.87
Prostate Stromal Cells, donor3	11405-118E1	148.49	59.02	38.69	5.42	6.47	4.07	4.28	2.50	1.25
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.55	33.94	29.20	3.65	0.73	0.00	0.73	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	41.10	97.31	39.78	7.42	0.62	0.90	0.14	0.49	0.14
Renal Epithelial Cells, donor1	11517-119H5	25.87	17.25	14.20	2.03	0.51	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	37.70	30.59	19.21	4.27	1.42	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	50.07	91.36	54.20	7.09	0.64	0.85	0.95	0.21	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	37.45	14.30	13.62	3.40	1.36	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	54.18	42.72	21.83	5.39	0.81	0.67	0.40	0.40	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	71.49	53.95	23.98	6.44	2.22	2.66	0.89	0.67	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	49.91	17.30	11.98	0.67	0.67	0.67	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	59.86	49.96	24.43	3.96	1.98	0.66	0.00	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	65.21	51.41	23.83	3.76	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	22.75	17.48	19.42	0.00	0.28	0.55	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	46.17	84.82	34.63	8.59	0.54	0.81	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	30.78	29.94	17.71	5.90	0.42	0.42	0.00	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	28.93	39.15	17.74	2.89	0.77	0.19	0.00	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	55.75	85.82	62.75	12.96	1.04	0.78	0.52	0.00	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	56.00	55.43	59.41	6.82	0.57	1.42	0.85	1.14	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	28.82	20.58	21.61	4.12	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.36	78.53	47.92	2.76	2.01	0.50	0.00	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	93.95	118.40	48.38	5.35	11.76	0.53	0.40	0.27	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	103.63	51.82	32.16	5.36	2.68	2.68	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	89.16	116.13	14.86	7.71	3.85	3.85	4.40	0.55	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	147.33	67.87	27.26	3.48	4.64	0.58	0.58	0.00	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	91.67	83.61	37.32	8.19	2.34	0.39	0.26	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	94.24	61.87	31.68	4.97	0.70	1.39	0.50	0.60	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	102.50	94.03	42.38	5.35	1.67	0.56	0.67	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	124.17	94.77	41.06	9.30	1.86	1.74	0.87	1.36	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	96.62	67.71	30.88	4.55	1.52	2.91	1.17	1.28	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	109.33	74.66	35.83	4.85	1.85	3.00	0.69	0.23	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	74.75	58.87	28.89	4.79	1.23	1.37	0.14	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	89.10	71.85	30.56	5.90	1.21	1.66	0.15	1.36	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	99.09	60.75	37.63	4.84	1.08	0.36	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	82.34	66.28	31.85	6.31	0.57	1.00	0.72	0.29	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	86.07	60.42	28.55	3.86	0.86	2.25	0.75	0.43	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	95.59	58.64	30.09	4.87	1.11	1.33	0.66	0.89	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	84.88	65.00	28.10	5.74	0.57	0.96	0.19	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	86.55	62.33	33.07	5.68	1.21	0.75	0.56	0.09	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	109.93	118.01	40.21	4.70	3.76	0.56	0.94	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	86.26	57.06	36.49	3.85	0.53	0.53	0.40	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	101.14	62.30	35.53	6.52	1.75	1.65	0.58	0.49	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	106.36	69.70	32.08	6.30	2.29	0.38	0.76	0.19	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	84.47	60.34	31.72	4.91	0.85	0.21	0.43	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	84.65	61.67	28.59	4.20	1.68	3.64	0.56	1.40	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	99.29	70.92	34.69	5.81	1.03	1.71	0.85	0.17	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	81.50	65.27	31.73	4.38	0.73	0.36	0.36	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	93.08	56.90	30.90	6.74	1.35	1.84	1.23	0.12	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	118.60	60.18	40.30	4.57	2.69	1.07	1.07	0.94	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	85.15	81.61	27.83	7.55	0.71	0.94	0.47	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	84.52	65.67	30.95	3.57	2.18	2.38	0.40	1.19	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	107.34	78.34	34.14	5.38	3.74	1.64	0.70	0.23	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	80.04	60.76	32.55	6.64	1.24	1.24	0.41	0.41	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	85.39	79.41	30.31	5.31	1.33	1.77	1.77	0.66	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	100.26	62.67	34.47	6.89	2.72	0.42	1.25	0.84	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	83.98	68.37	31.09	5.25	1.08	1.48	0.27	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	104.56	59.60	34.06	5.79	1.36	0.85	0.00	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	100.25	64.01	31.43	5.59	2.70	1.16	0.39	0.39	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	71.01	83.91	24.93	8.08	2.24	1.38	1.20	0.86	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	92.86	61.59	34.98	4.39	3.02	0.41	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	82.41	72.40	31.03	6.07	2.46	0.82	2.30	1.31	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	78.91	62.21	31.36	4.60	0.34	1.02	0.17	0.34	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	96.47	68.95	35.07	5.03	2.07	0.89	0.44	0.15	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	94.89	47.45	31.45	2.67	0.80	0.27	0.53	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	88.08	45.07	37.19	3.18	0.41	1.38	0.28	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	97.86	49.05	32.86	4.05	1.19	0.48	0.95	0.24	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	118.10	60.06	37.89	5.64	1.21	0.81	0.81	0.81	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	81.18	46.90	29.85	4.24	0.75	1.51	0.75	0.94	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	116.34	72.67	35.98	1.75	2.45	3.49	2.10	1.75	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	106.68	56.21	33.85	3.93	0.60	0.91	0.60	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	86.89	59.48	27.90	4.53	0.86	1.47	0.73	0.49	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	125.32	77.29	49.78	3.49	2.04	0.44	0.73	0.15	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	110.13	46.85	26.16	3.04	1.83	3.65	0.61	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	90.12	56.06	28.93	4.22	0.00	0.60	0.60	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	123.50	51.12	27.82	3.62	0.90	2.71	0.90	0.23	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	140.18	62.90	39.54	4.49	1.80	0.90	1.20	0.30	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	104.14	58.68	32.23	3.90	1.18	0.94	2.72	0.35	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	131.06	56.99	34.36	4.48	1.07	1.28	4.06	1.92	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	106.97	47.48	39.06	1.20	1.80	0.00	0.60	0.00	1.80
Schwann Cells, donor1	11498-119F4	50.40	22.94	23.51	6.96	0.75	0.56	0.19	0.19	0.19
Schwann Cells, donor2	11578-120F3	51.04	34.02	27.22	3.40	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	84.78	48.20	32.42	3.29	2.85	2.41	0.88	0.22	1.31
Sebocyte, donor1	11220-116B5	152.28	195.01	76.69	16.43	6.03	0.00	1.10	0.00	0.55
Sebocyte, donor2	11301-117B5	54.23	67.55	40.44	7.35	1.84	2.76	0.92	0.46	0.46
Sebocyte, donor3	11378-118B1	74.82	72.96	32.98	2.68	1.65	2.27	0.62	0.00	1.65
Sertoli Cells, donor1	11255-116F4	265.06	104.37	66.26	9.94	13.25	4.97	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	132.75	67.78	81.91	2.82	0.00	8.47	5.65	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	89.47	46.10	68.53	4.31	1.67	0.53	2.11	0.09	0.18
Skeletal Muscle Cells, donor2	11358-117H8	91.08	11.57	32.53	3.61	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	119.55	34.28	25.92	2.51	0.84	0.00	0.84	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	110.44	76.66	24.35	8.64	4.40	0.63	0.16	0.79	0.79
Skeletal Muscle Cells, donor5	11455-119A6	107.32	72.54	29.88	7.73	3.42	1.04	1.49	0.59	0.15
Skeletal Muscle Cells, donor6	11459-119B1	122.04	72.95	28.47	10.93	3.23	1.08	1.23	0.15	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	193.67	151.46	54.06	12.35	12.47	2.02	1.64	1.26	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	192.77	76.20	50.94	7.13	4.85	3.57	1.43	1.43	3.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	136.22	90.28	27.18	8.43	3.87	1.49	0.69	1.29	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	198.33	100.09	85.77	3.79	8.59	1.52	1.35	0.25	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	79.61	28.95	38.36	4.34	3.62	2.90	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	95.63	41.69	24.36	4.68	2.48	0.69	0.96	0.14	0.41
Skin - palm, donor1	10286-104F7	61.78	10.74	34.92	0.00	8.06	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	33.88	60.83	20.33	3.03	1.30	1.30	0.86	0.00	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	44.17	108.78	17.99	8.18	1.64	2.45	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	30.51	86.72	18.57	4.93	0.52	0.78	0.39	0.00	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	75.48	116.07	33.08	6.53	1.95	1.67	1.25	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	77.64	51.48	40.09	5.20	1.13	1.13	0.42	0.14	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	36.58	160.70	23.89	6.34	0.85	0.21	0.42	0.21	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	74.80	49.02	45.27	2.77	0.75	1.57	0.45	0.45	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	214.16	110.78	48.76	8.64	9.26	7.71	5.25	1.85	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	161.41	76.70	20.90	3.56	5.34	2.22	0.89	0.44	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	167.53	69.95	46.44	8.82	7.64	0.00	1.18	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	113.59	135.69	24.97	7.51	3.98	0.44	0.44	0.00	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	179.56	98.84	30.32	7.88	9.45	0.79	1.18	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	157.60	77.26	52.53	13.13	10.82	0.77	0.77	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	132.10	75.06	34.03	7.01	1.00	2.00	3.00	1.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	194.56	90.49	45.65	7.05	12.51	1.33	1.73	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	190.62	75.58	39.01	8.42	9.53	3.55	2.66	1.55	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	271.81	99.61	91.41	11.65	19.33	1.15	0.90	0.51	1.54
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	161.49	66.42	31.91	7.49	10.09	0.65	0.65	0.65	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	163.02	86.53	53.16	6.50	10.93	0.89	0.00	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	154.61	57.23	41.57	3.99	3.27	1.71	1.57	0.85	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	36.93	22.45	10.74	3.09	0.81	0.81	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	90.42	39.88	35.01	1.83	2.44	1.22	0.61	1.52	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	264.43	81.07	45.97	11.11	4.80	0.51	1.77	0.00	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	165.26	171.38	6.12	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	104.43	33.86	17.64	6.20	1.91	1.43	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	131.84	114.00	40.70	9.14	7.96	0.88	0.88	0.59	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	143.56	91.05	24.32	5.38	4.95	3.44	0.65	0.65	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	137.70	87.43	24.46	6.40	4.62	1.26	0.73	1.36	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	208.20	106.26	33.57	9.90	13.30	0.15	1.39	0.46	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	149.82	63.59	31.26	4.31	24.79	3.23	1.08	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	141.66	53.79	40.94	4.48	3.89	0.30	0.30	0.00	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	69.30	27.65	19.46	4.78	1.02	1.02	0.34	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	179.12	128.71	78.61	6.67	3.53	1.96	0.94	0.39	0.86
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	170.89	107.59	98.23	11.67	26.07	2.31	11.37	1.11	1.51
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	99.44	56.21	21.62	4.10	4.55	1.14	0.91	0.00	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	158.80	61.59	22.34	7.25	6.64	1.21	3.02	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	105.18	145.44	30.73	14.84	4.50	1.59	0.00	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	187.09	107.73	47.40	14.11	10.39	1.20	1.46	0.53	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	177.31	97.17	51.47	6.89	9.27	3.88	2.88	3.01	2.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	210.79	72.55	38.30	7.61	5.83	1.52	2.03	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	263.40	125.14	56.54	12.51	10.10	0.15	1.36	1.06	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	115.53	46.51	23.26	6.75	5.25	1.50	1.50	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	56.86	447.11	16.80	29.72	0.00	0.00	0.00	2.58	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	268.35	81.85	48.83	3.26	12.09	0.93	1.86	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	128.24	71.19	41.91	4.54	11.11	5.05	1.51	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	133.19	48.58	25.07	4.07	9.72	1.57	0.94	0.63	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	51.62	23.01	22.71	2.95	2.36	0.29	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	154.12	113.71	45.57	9.66	5.91	0.75	0.17	0.08	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	114.92	53.26	36.44	1.87	3.27	1.87	0.00	0.47	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	216.45	66.06	55.12	6.62	14.10	0.86	1.30	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	151.95	70.62	39.26	7.90	5.10	1.78	0.51	1.53	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	132.56	64.31	24.26	5.45	3.95	1.13	0.56	0.19	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	135.97	102.57	49.19	13.56	6.71	0.56	0.56	0.14	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	215.42	75.24	59.66	5.61	6.62	0.34	0.92	0.34	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	55.71	16.19	10.48	2.86	1.43	1.43	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	205.76	65.57	51.87	6.85	16.64	1.22	0.98	0.49	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	187.36	105.83	60.98	8.62	8.84	2.43	2.87	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	78.41	55.88	30.14	8.19	2.34	0.29	1.46	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	139.16	48.01	46.84	2.72	3.50	0.97	0.78	1.17	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	88.59	63.47	25.39	5.82	3.97	0.79	1.32	1.85	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	83.32	119.02	20.46	8.55	8.55	2.98	2.98	3.72	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	164.58	91.27	42.76	8.98	11.14	3.23	1.80	2.16	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	78.36	63.59	32.65	5.39	5.39	1.14	0.28	0.57	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	107.53	74.05	28.75	14.97	4.33	4.33	1.18	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	97.77	45.71	24.38	4.06	5.33	4.83	1.78	2.29	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	119.40	36.34	49.91	0.00	2.00	3.19	1.60	1.60	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	109.52	41.38	34.28	3.34	3.76	2.51	1.67	1.25	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	113.22	54.09	28.88	4.13	2.29	0.92	0.46	3.21	0.92
Synoviocyte, donor1	11291-117A4	210.57	96.45	42.42	3.37	9.09	2.19	1.85	0.67	0.34
Synoviocyte, donor2	11368-117I9	103.93	56.99	29.84	2.51	3.18	2.01	0.67	0.67	0.50
Synoviocyte, donor3	11440-118H9	96.51	38.65	58.53	2.90	3.35	3.35	1.56	0.45	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	98.62	41.81	29.30	8.22	2.86	1.07	0.00	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	57.48	27.75	19.82	5.95	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	66.22	20.61	21.77	1.85	0.46	0.23	0.00	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	65.45	97.42	35.41	8.39	0.79	0.79	0.57	0.07	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	37.11	31.70	16.24	3.48	0.39	0.00	0.39	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	40.66	38.37	22.33	5.73	0.57	0.00	0.57	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	93.01	121.55	50.69	5.41	12.30	1.60	1.11	0.00	0.74
Urethra, donor2	10319-105A4	84.53	35.97	35.97	1.80	1.80	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	25.50	27.10	26.57	1.06	0.27	0.27	0.27	0.53	0.00
Urothelial Cells, donor2	11600-120H7	45.26	37.25	23.23	2.40	0.00	1.60	0.40	0.40	0.40
Urothelial Cells, donor3	11681-122H7	33.23	18.34	22.00	2.98	0.00	0.69	0.46	0.23	0.23
Urothelial cells, donor0	11216-116B1	123.71	91.16	88.71	12.04	0.89	1.34	1.34	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	2.67	125.46	26.69	17.80	0.89	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	2.86	121.52	41.46	17.16	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	4.11	56.13	19.17	6.16	0.68	2.05	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	8.26	80.58	18.59	6.89	1.38	0.34	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	9.30	105.75	22.66	8.13	0.58	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	6.25	109.33	18.74	12.49	2.08	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	5.51	82.60	44.97	14.68	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	1.83	44.73	13.69	3.65	0.91	0.00	0.91	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	31.21	84.26	52.55	5.55	1.48	1.48	0.74	0.25	0.62
Wilms' tumor cell line:HFWT	10597-108E3	71.28	33.44	79.20	5.28	0.88	0.00	0.88	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	93.01	50.84	35.47	11.73	0.28	1.12	0.00	0.56	0.00
achilles tendon, donor2	10292-104G4	74.40	70.26	24.80	2.07	0.00	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	87.70	134.87	56.86	6.12	1.78	2.55	0.25	1.27	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	30.41	110.75	19.04	4.88	0.00	0.00	0.00	0.00	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	32.64	42.26	5.10	0.00	0.12	0.12	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	107.48	52.79	9.25	0.00	0.82	0.54	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	23.33	98.94	36.54	6.18	1.41	2.81	0.56	0.28	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	25.17	46.31	20.94	2.33	0.63	0.00	0.42	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	85.20	99.09	22.87	5.99	2.18	1.36	0.54	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	33.93	35.25	18.95	4.41	1.76	0.88	0.44	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	23.28	57.58	40.84	5.72	2.86	1.63	0.41	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	45.43	74.16	24.46	3.11	1.55	0.78	0.39	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	19.50	68.08	25.39	6.81	1.29	1.47	0.18	0.74	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	39.01	42.91	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	49.73	100.85	27.42	9.99	2.09	1.39	0.23	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	23.56	87.25	9.06	13.20	1.04	0.78	0.52	0.52	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	22.80	98.78	17.24	8.18	1.75	0.58	0.88	0.88	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	30.67	43.22	49.73	5.58	3.25	0.46	0.00	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	12.75	17.68	10.28	2.06	0.00	0.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	38.37	70.60	54.94	9.21	1.23	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	42.67	116.06	43.10	15.36	5.12	2.13	0.85	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	39.73	131.33	47.92	10.31	2.73	0.00	0.30	0.30	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	37.07	154.05	39.96	12.52	4.33	0.48	0.24	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	21.38	69.94	20.27	11.58	1.78	0.45	0.89	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	24.68	52.03	27.68	8.01	0.67	0.33	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	39.02	63.18	26.01	11.15	3.72	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	33.15	104.71	19.21	8.66	1.88	0.75	0.38	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	63.24	35.33	24.42	2.62	1.74	0.44	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	37.49	43.11	48.74	0.00	3.75	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	21.19	34.85	25.67	8.24	2.35	0.47	0.47	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	54.29	71.82	68.10	5.43	4.03	1.09	1.09	0.31	0.31
adipose, donor1	10184-103D4	11.14	91.48	39.88	15.25	0.00	0.59	1.76	0.00	0.00
adipose, donor2	10185-103D5	11.35	30.01	36.50	5.68	0.00	0.41	1.22	0.00	0.00
adipose, donor3	10186-103D6	25.87	60.99	33.49	3.81	1.09	0.54	1.63	0.27	1.09
adipose, donor4	10187-103D7	102.28	159.48	29.47	10.40	0.00	2.60	1.73	0.87	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	38.98	123.57	56.18	8.05	1.74	0.47	0.16	0.32	0.16
adrenal gland, adult, pool1	10081-102A9	65.48	29.10	21.83	3.64	7.28	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	8.94	30.55	22.15	7.20	0.27	0.00	0.00	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	63.24	65.03	42.52	10.00	1.43	2.14	0.71	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	88.57	35.47	94.59	3.71	4.17	0.23	0.70	0.00	0.70
amniotic membrane cells, donor2	12236-129G4	92.64	58.83	70.33	13.86	15.89	1.01	1.35	0.34	0.68
amniotic membrane cells, donor3	12237-129G5	74.53	45.37	105.17	7.66	3.54	2.95	1.18	1.77	0.29
amygdala - adult, donor10196	10167-103B5	8.30	59.29	53.36	7.11	0.00	0.00	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	24.33	46.43	60.83	3.24	0.81	1.42	0.41	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	24.85	37.76	29.37	1.61	1.94	0.65	0.00	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	244.47	113.20	94.22	3.31	8.40	0.89	2.16	0.64	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	12.58	48.32	22.06	9.93	0.00	1.32	0.22	0.66	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	56.79	65.14	99.21	2.00	0.67	1.34	0.00	0.33	0.00
aorta, adult, pool1	10052-101G7	89.44	29.03	56.49	2.16	4.71	1.57	0.20	0.78	0.20
appendix, adult	10189-103D9	31.05	65.20	21.73	2.72	1.55	0.00	0.00	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	24.08	120.38	28.55	10.32	0.34	0.00	1.03	0.69	0.00
artery, adult	10190-103E1	25.82	92.39	66.58	2.72	2.72	2.72	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	32.88	96.05	62.44	5.79	2.03	0.58	0.29	0.00	0.29
b cell line:RPMI1788	10427-106D4	106.62	80.00	43.42	4.76	8.33	0.00	0.89	0.15	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	204.20	78.24	54.66	5.83	8.60	1.66	1.39	0.83	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	42.27	120.47	34.53	15.88	1.69	0.89	0.10	0.30	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	50.21	80.68	105.28	3.18	2.01	1.00	0.33	0.67	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	31.88	39.15	34.11	2.80	1.12	0.00	0.00	0.00	1.12
bladder, adult, pool1	10011-101C2	72.79	62.25	33.90	2.28	1.09	0.76	0.98	0.11	0.33
blood, adult, pool1	10053-101G8	0.00	22.15	24.36	6.64	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	101.91	77.93	41.96	11.13	5.99	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	74.91	87.05	30.37	0.67	6.07	4.05	2.02	1.35	2.02
brain, adult, donor1	10084-102B3	11.28	36.90	66.63	5.13	0.00	1.03	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	10.02	52.67	51.00	4.68	0.78	1.00	0.11	0.22	0.22
brain, fetal, pool1	10085-102B4	10.69	29.39	69.46	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	65.08	37.00	47.57	2.31	1.98	1.32	0.99	0.99	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	131.94	71.15	61.16	2.87	17.72	0.37	0.12	0.25	0.25
breast, adult, donor1	10080-102A8	86.50	29.04	39.78	8.21	0.63	0.63	0.63	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	47.77	65.68	34.43	4.07	1.02	1.14	0.25	0.89	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	35.87	75.45	66.17	0.62	7.73	1.55	0.31	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	88.86	111.20	26.01	8.29	3.22	4.83	0.46	2.07	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	38.25	98.53	74.80	5.57	6.05	2.66	0.48	0.24	0.97
carcinoid cell line:NCI-H1770	10703-109H1	27.74	39.96	16.46	9.87	1.88	0.94	1.41	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	84.66	63.88	60.49	3.94	0.98	0.98	0.00	0.11	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	54.51	77.96	58.63	5.70	0.00	1.90	1.27	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	78.26	71.07	48.44	4.26	0.53	1.60	0.53	0.80	1.06
caudate nucleus - adult, donor10196	10177-103C6	17.27	49.51	50.66	3.45	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	22.42	52.54	51.54	3.35	1.84	1.00	0.17	0.84	0.17
caudate nucleus, adult, donor10258	10379-105H1	3.06	48.14	42.79	5.35	0.00	0.00	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	26.00	61.53	31.13	1.10	1.83	0.37	0.37	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	23.31	52.44	81.57	0.00	0.00	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	33.09	91.81	52.74	9.18	0.21	1.28	0.43	0.21	0.43
cerebellum, adult, pool1	10083-102B2	6.21	22.08	40.70	1.72	0.34	1.03	0.00	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	18.27	64.76	44.84	1.66	1.66	1.66	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	14.62	30.76	44.12	2.52	0.50	0.00	0.25	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	45.31	73.09	65.05	0.73	2.92	0.73	0.73	1.46	1.46
cervical cancer cell line:D98-AH2	10552-107I3	66.57	75.20	119.20	3.74	7.19	0.72	0.58	1.15	0.14
cervical cancer cell line:ME-180	10553-107I4	126.61	86.67	67.61	3.65	0.50	0.33	0.33	0.50	0.17
cervix, adult, pool1	10013-101C4	90.92	73.91	53.44	2.20	5.56	1.05	1.36	0.52	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	125.68	65.91	59.78	7.52	6.41	0.84	0.98	0.00	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	99.28	26.13	78.38	2.61	2.61	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	75.06	102.65	60.52	15.66	4.97	1.37	3.60	0.50	0.37
choriocarcinoma cell line:SCH	10785-110H2	64.07	58.16	48.42	4.93	2.46	1.23	0.49	0.25	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	33.44	127.60	75.90	14.47	4.51	0.71	0.71	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	54.99	39.60	61.83	3.13	4.84	0.85	0.28	0.85	0.57
chorionic membrane cells, donor2	12239-129G7	159.29	73.38	59.16	9.15	7.16	0.89	2.59	1.39	0.60
chorionic membrane cells, donor3	12240-129G8	67.59	70.33	79.68	4.40	6.59	6.04	0.55	1.65	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	24.24	18.18	7.07	0.00	2.02	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	36.11	57.63	19.98	4.03	0.77	0.38	0.19	0.58	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	31.26	53.64	35.06	4.01	1.48	0.42	0.00	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	5.39	73.19	9.24	7.19	0.26	0.00	0.00	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	5.32	74.50	11.37	10.88	0.97	0.48	0.00	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	7.74	83.89	14.25	8.96	0.41	0.81	0.81	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	4.42	139.87	17.67	14.43	0.00	0.29	0.59	0.88	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	42.74	87.57	40.66	6.26	2.09	0.26	0.00	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	35.66	49.83	36.34	1.60	1.14	2.06	1.14	0.69	2.06
clear cell carcinoma cell line:TEN	10636-108I6	68.01	117.29	36.96	5.73	7.46	0.69	0.00	1.04	0.69
colon carcinoma cell line:CACO-2	10513-107D9	49.97	134.54	19.95	7.69	3.29	0.73	0.37	0.37	0.37
colon carcinoma cell line:COLO-320	10420-106C6	142.91	104.90	69.55	7.60	0.76	1.14	1.14	0.38	0.38
colon, adult, donor1	10082-102B1	39.27	60.69	48.79	4.76	1.19	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	51.82	96.24	40.42	2.23	1.88	0.47	2.00	0.35	0.12
colon, fetal, donor1	10070-101I7	43.26	54.38	43.88	2.47	1.24	0.00	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	22.92	36.67	178.76	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	46.32	109.21	18.27	10.20	0.85	0.00	0.42	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	56.00	118.33	15.24	7.09	3.32	0.00	1.21	0.15	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	60.92	128.46	21.72	9.87	2.68	0.71	0.14	0.28	0.14
corpus callosum, adult, pool1	10042-101F6	36.71	78.28	79.05	4.09	1.66	0.66	0.44	0.22	0.11
cruciate ligament, donor2	10295-104G7	51.87	51.87	45.39	1.62	1.62	0.00	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	65.81	63.40	83.47	4.82	3.21	0.00	0.00	0.80	0.00
diencephalon, adult	10193-103E4	11.04	39.84	43.20	4.80	0.24	0.24	0.24	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	3.21	56.94	21.58	2.98	0.00	2.07	0.46	0.92	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	18.72	131.04	45.90	5.13	1.28	0.51	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	158.40	93.16	99.90	7.70	1.93	2.65	0.48	0.72	0.72
ductus deferens, adult	10196-103E7	115.61	70.76	38.37	2.99	9.47	0.50	0.50	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	90.73	64.81	44.65	0.00	5.76	2.88	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	99.31	67.68	45.61	5.89	8.83	5.15	0.74	0.00	1.47
dura mater, adult, donor1	10041-101F5	97.87	63.51	60.95	2.81	6.28	0.17	0.25	0.17	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	31.76	93.05	14.66	11.55	0.89	0.67	2.00	0.44	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	42.84	133.41	14.76	17.48	0.57	1.00	0.29	0.57	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	33.91	20.96	56.11	1.23	0.00	0.62	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	27.24	28.15	40.56	1.82	0.30	0.91	0.30	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	37.67	34.89	66.07	4.63	2.47	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	28.90	27.58	70.93	1.31	2.63	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	52.29	31.17	66.37	2.68	6.37	0.67	0.34	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	54.01	83.19	65.97	8.16	2.54	1.99	0.36	0.18	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	75.42	79.12	57.09	2.41	3.54	4.82	1.77	1.61	0.96
epidermoid carcinoma cell line:A431	10426-106D3	64.58	50.35	50.13	3.33	0.89	0.67	0.11	0.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	39.92	113.07	41.13	11.44	0.77	0.55	0.11	0.22	0.33
epididymis, adult	10197-103E8	102.56	66.35	64.89	1.67	24.91	2.30	1.05	1.05	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	70.25	84.62	68.30	13.13	2.31	1.42	1.06	0.71	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	94.38	71.18	19.66	2.36	1.18	0.79	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	31.32	72.99	23.59	8.91	1.05	1.70	0.79	0.52	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	37.60	62.30	27.26	9.74	0.89	1.97	0.39	1.08	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	31.37	69.79	25.65	9.41	0.67	1.01	0.56	0.90	0.56
esophagus, adult, pool1	10015-101C6	62.22	72.63	44.28	4.46	3.29	0.32	1.27	0.53	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	198.50	165.06	59.86	3.01	5.76	0.88	1.13	0.38	0.13
eye - muscle inferior rectus, donor1	10272-104E2	16.90	31.39	45.88	0.00	0.00	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	33.67	67.33	84.17	6.31	2.10	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	25.30	25.30	122.03	1.49	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	30.96	43.57	74.52	3.44	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	32.06	34.98	32.06	1.46	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	75.25	46.02	62.80	3.31	3.56	2.03	1.27	1.02	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	39.75	61.93	44.75	7.69	0.26	1.15	0.90	0.13	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	63.15	94.97	40.12	10.68	1.66	2.37	1.19	0.47	0.24
frontal lobe, adult, pool1	10040-101F4	12.57	78.06	79.19	8.35	0.38	0.38	0.09	0.09	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	38.43	74.46	17.41	3.00	2.10	1.50	0.30	1.20	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	82.29	93.91	64.92	5.03	6.22	0.82	0.55	0.37	0.18
gall bladder, adult	10198-103E9	62.53	59.63	49.98	3.62	3.86	1.21	0.48	0.48	0.72
gamma delta positive T cells, donor1	11937-126A2	3.22	37.04	24.16	1.61	0.54	0.54	1.07	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	4.11	31.00	19.80	2.99	2.61	0.37	0.00	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	58.08	42.67	39.08	2.53	2.53	2.11	0.63	1.06	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	111.41	84.14	86.84	2.13	4.64	2.51	0.39	0.58	0.77
gastric cancer cell line:AZ521	10549-107H9	110.01	229.54	65.25	20.00	2.13	0.16	0.98	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	50.34	52.17	17.39	3.66	0.92	2.75	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	88.64	62.60	28.33	1.83	1.37	2.51	1.60	0.46	0.91
giant cell carcinoma cell line:LU65	10487-107B1	22.83	23.06	23.52	2.75	1.03	0.57	0.11	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	135.76	117.71	50.95	11.06	2.38	0.42	0.98	0.42	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	21.45	52.63	52.13	3.24	1.25	1.25	0.00	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	112.41	70.51	70.83	11.51	2.11	1.06	0.21	0.21	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	126.54	72.89	80.19	11.80	3.79	1.54	0.56	0.56	0.28
glioblastoma cell line:T98G	10485-107A8	121.19	106.84	46.14	14.35	5.08	0.99	0.33	0.44	0.66
glioma cell line:GI-1	10413-106B8	145.85	47.45	40.71	6.15	1.76	0.59	1.76	1.17	0.00
globus pallidus - adult, donor10196	10175-103C4	16.76	32.07	40.09	3.64	0.00	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	53.70	68.83	52.97	2.69	0.49	1.46	0.00	0.98	0.98
globus pallidus, adult, donor10258	10367-105F7	10.95	35.60	38.34	1.37	0.00	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	26.65	49.03	35.71	1.07	0.53	1.07	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	26.92	31.81	195.77	4.89	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	21.86	10.93	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	10.45	31.36	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	138.56	37.44	62.40	5.12	4.80	3.20	1.28	0.64	0.96
hIPS +CCl2, biol_rep1	14383-156B9	50.50	72.54	23.87	5.97	0.46	1.38	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	45.27	62.19	23.78	16.00	0.46	0.91	0.46	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	52.17	33.49	29.63	7.73	0.64	0.00	0.00	1.29	1.29
hIPS, biol_rep1	14380-156B6	63.24	57.49	11.50	18.68	0.00	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	58.98	37.72	21.95	9.60	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	14.35	32.00	36.41	4.41	0.00	0.00	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	12.64	34.77	14.37	5.46	1.15	0.57	0.57	0.57	0.57
heart - mitral valve, adult	10205-103F7	66.97	41.86	59.20	1.49	3.59	0.90	0.30	0.30	0.90
heart - pulmonic valve, adult	10206-103F8	38.44	72.69	82.89	3.40	1.31	0.26	1.05	0.26	0.78
heart - tricuspid valve, adult	10207-103F9	105.75	59.12	41.63	3.33	5.00	1.67	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	52.85	64.48	52.65	5.10	3.47	2.65	0.20	1.22	0.61
heart, adult, diseased, donor1	10051-101G6	30.23	83.46	75.80	2.55	2.55	0.85	0.43	1.28	1.28
heart, adult, pool1	10016-101C7	52.66	64.85	87.16	4.83	1.15	0.23	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	70.64	118.39	85.43	3.59	2.57	0.41	0.10	0.21	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	298.34	69.11	54.92	3.70	10.18	0.00	0.31	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	160.54	42.81	36.86	5.95	1.19	1.19	2.38	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	197.68	230.05	41.44	14.36	12.38	4.09	1.44	1.55	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	214.10	243.96	49.04	15.66	14.32	5.58	1.21	3.03	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	226.06	277.29	53.56	15.36	14.75	4.75	1.11	2.43	1.92
hepatoma cell line:Li-7	10484-107A7	58.50	70.73	26.36	4.78	0.22	0.44	0.33	0.56	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	51.86	39.90	5.53	0.00	0.30	0.10	0.60	0.20
hippocampus - adult, donor10196	10169-103B7	14.19	45.42	42.58	6.62	0.00	0.95	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	31.02	46.33	60.41	3.27	1.22	1.02	0.41	0.61	0.20
hippocampus, adult, donor10258	10374-105G5	2.49	29.38	42.33	6.97	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	18.33	43.35	44.06	1.76	1.06	0.35	0.35	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	24.41	133.05	25.63	14.65	0.61	3.66	1.22	1.22	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	12.96	76.58	28.28	9.43	0.20	0.79	0.79	0.39	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	17.77	83.53	28.69	9.65	0.25	0.76	1.02	0.76	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	12.41	59.77	29.32	2.26	0.00	0.00	1.69	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	14.20	58.36	37.96	5.16	0.00	3.10	4.13	1.29	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	11.77	77.82	25.43	3.80	0.00	0.38	1.90	0.38	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	17.23	73.86	44.08	4.38	0.29	0.58	2.92	0.29	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	16.16	67.64	49.76	5.60	1.29	0.86	3.88	0.86	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	20.02	77.58	36.70	3.34	0.42	0.00	3.34	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	32.20	74.83	43.81	3.79	0.95	0.00	1.89	0.24	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	27.00	95.95	45.48	4.82	0.64	1.45	1.93	0.32	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	26.93	72.72	47.13	5.39	1.35	0.00	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	20.03	94.67	35.05	8.76	0.00	1.41	2.03	0.16	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	19.16	88.92	29.48	11.30	0.00	4.42	2.95	0.98	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	16.58	154.48	11.35	13.09	0.87	1.75	0.00	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	10.88	86.48	39.52	4.01	0.00	0.19	2.29	0.19	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	9.59	65.41	35.32	5.67	0.44	0.00	2.18	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	7.50	81.46	37.48	4.00	0.00	0.00	1.50	0.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	11.87	63.11	41.26	4.14	0.75	0.19	2.83	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	13.19	60.93	36.38	0.91	0.45	0.45	1.82	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	11.90	51.06	33.20	3.13	0.31	1.25	2.19	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.84	54.05	41.81	1.63	1.14	0.49	1.96	0.33	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	19.45	50.80	45.00	5.23	1.45	0.58	2.90	1.45	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.32	46.63	37.66	1.49	0.90	1.20	1.49	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	21.98	93.11	29.93	6.84	0.18	1.11	1.29	0.92	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	25.96	75.89	31.67	7.70	0.00	1.14	1.43	0.00	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	28.58	126.17	28.99	9.39	0.00	2.45	2.86	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	20.07	56.68	36.97	6.69	0.00	1.06	3.52	0.35	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.47	60.18	36.11	4.43	0.00	0.95	4.12	0.63	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	15.13	72.93	33.59	4.84	0.91	0.30	3.03	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	19.13	60.50	44.47	1.03	1.03	0.52	2.59	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.30	60.44	31.88	3.32	0.66	0.00	2.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.39	51.31	31.55	3.59	2.57	0.51	1.54	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	29.66	81.81	41.16	4.86	2.56	2.30	4.09	0.77	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	27.26	74.97	30.29	1.51	1.51	0.00	2.27	0.76	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	34.95	81.66	34.61	3.70	1.68	1.34	2.02	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	24.39	68.83	34.05	12.80	0.00	1.69	1.21	0.48	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	19.61	78.88	21.84	6.24	0.00	0.89	1.34	0.45	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	20.49	73.66	33.66	8.29	0.00	0.00	0.98	0.98	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	16.81	81.60	42.79	6.72	0.92	0.61	2.75	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	250.50	68.32	61.81	0.00	6.51	19.52	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	21.18	118.48	38.39	8.60	0.66	0.33	1.99	0.99	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	18.61	68.41	50.35	4.38	0.55	0.00	2.74	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	15.20	76.72	31.85	4.34	0.00	1.09	2.53	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	11.74	67.62	37.01	3.91	0.00	0.00	1.78	0.71	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	20.29	72.80	33.41	5.97	0.00	0.00	3.58	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	38.33	100.49	64.46	4.88	1.35	0.41	2.03	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	26.40	54.96	31.52	4.31	0.81	0.00	0.54	0.54	1.08
immature langerhans cells, donor1	11904-125F5	62.23	42.86	14.04	1.45	5.09	0.24	0.24	0.73	0.00
immature langerhans cells, donor2	11905-125F6	32.48	26.93	15.84	0.79	2.38	0.00	0.00	0.79	0.79
insula, adult, pool1	10039-101F3	10.32	95.20	82.71	6.15	0.19	0.57	0.00	0.28	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	42.92	30.89	46.82	3.58	1.30	0.98	1.95	0.33	0.33
kidney, adult, pool1	10017-101C8	45.66	98.12	48.06	4.31	5.41	0.80	0.60	0.40	0.30
kidney, fetal, pool1	10045-101F9	72.01	79.01	66.35	2.62	4.10	0.57	0.42	0.14	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	69.45	158.50	39.20	8.66	3.27	0.57	0.85	0.28	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	55.30	33.73	34.42	2.63	1.52	0.83	0.69	1.11	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	35.60	28.44	49.18	3.67	1.47	0.18	0.18	0.18	0.18
left atrium, adult, donor1	10079-102A7	43.04	37.59	76.82	1.63	2.72	1.09	0.00	1.63	1.63
left ventricle, adult, donor1	10078-102A6	29.83	41.46	59.16	0.51	0.51	0.51	2.02	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	199.46	133.52	65.94	6.02	4.38	0.82	0.82	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	93.05	82.27	43.83	5.39	8.98	2.51	4.67	1.44	4.31
leiomyoma cell line:15242A	10570-108B3	78.80	76.63	34.78	5.98	9.24	3.80	2.17	0.54	2.17
leiomyoma cell line:15425	10571-108B4	94.21	91.54	35.69	7.77	7.28	7.28	1.46	1.70	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	126.99	31.75	63.49	6.35	0.00	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	39.73	30.32	29.28	5.23	1.05	1.05	1.05	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	42.50	72.37	23.61	2.83	1.42	0.83	0.00	0.35	0.24
liposarcoma cell line:KMLS-1	10782-110G8	106.69	92.16	30.46	9.84	12.50	2.66	0.47	0.94	0.78
liposarcoma cell line:SW 872	10726-110A6	70.54	56.29	28.88	6.82	2.31	0.37	0.12	0.24	0.00
liver, adult, pool1	10018-101C9	211.81	117.01	56.88	3.57	24.96	1.46	1.62	0.49	0.81
liver, fetal, pool1	10086-102B5	71.49	34.81	38.57	0.94	6.58	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	19.10	45.06	42.14	2.33	0.58	0.15	0.00	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	31.19	40.97	39.49	3.88	0.00	1.29	0.74	0.55	0.00
locus coeruleus, adult, donor10258	10375-105G6	10.44	34.99	42.88	3.10	1.13	1.13	0.28	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	28.18	79.50	23.98	3.36	0.84	0.84	0.84	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	157.22	92.17	66.71	9.41	8.44	1.25	0.14	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	162.70	147.53	120.65	24.82	15.17	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	72.63	51.67	76.85	1.98	5.27	1.45	0.66	0.40	0.26
lung, adult, pool1	10019-101D1	70.76	49.61	42.29	4.25	5.08	1.06	1.06	0.12	0.00
lung, fetal, donor1	10068-101I5	90.19	129.86	40.53	7.99	5.99	1.14	1.43	0.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	39.41	48.11	23.83	1.83	3.67	1.37	0.92	0.92	0.92
lymph node, adult, donor1	10077-102A5	34.08	37.40	18.46	2.37	2.84	0.00	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	83.29	49.31	29.59	7.01	2.19	1.97	0.22	1.10	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	23.85	127.68	27.47	4.08	3.17	1.06	0.45	0.45	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	57.77	61.16	61.16	0.00	2.55	0.00	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	44.40	48.39	186.92	5.77	2.66	0.00	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	54.58	57.07	144.65	7.47	2.28	0.83	0.00	0.00	0.42
mature adipocyte, donor3	12233-129G1	55.47	55.95	143.19	4.74	3.79	0.47	0.24	0.00	0.24
mature adipocyte, donor4	12234-129G2	40.80	80.54	112.92	8.69	3.69	0.53	0.26	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	160.35	148.67	101.50	7.15	3.10	0.48	1.19	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	55.27	42.87	13.54	0.00	1.13	0.00	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	23.72	53.33	49.47	2.76	0.55	1.29	0.37	0.37	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	3.49	39.39	34.63	4.77	0.00	1.27	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	21.32	61.41	26.87	4.26	1.71	1.28	0.00	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	8.78	59.23	49.44	3.54	0.00	4.22	0.51	0.51	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	22.50	56.03	42.02	3.61	0.42	0.42	0.21	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	15.41	19.26	3.85	0.00	0.00	1.93	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	129.18	14.35	0.00	0.00	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	17.23	40.56	39.84	0.00	0.36	0.36	0.36	0.00	0.72
medulla oblongata - adult, donor10196	10174-103C3	36.34	29.85	37.64	3.89	1.30	1.95	0.00	1.95	0.65
medulla oblongata, adult, donor10252	10155-103A2	55.42	47.22	45.36	3.72	2.17	1.08	0.46	0.31	0.31
medulla oblongata, adult, pool1	10038-101F2	27.18	53.87	60.24	5.39	0.65	0.57	0.08	0.16	0.08
medulla oblongata, newborn, donor10223	10361-105F1	30.90	46.18	35.07	1.04	0.69	1.39	0.00	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	113.81	38.97	56.24	2.88	0.66	2.66	0.66	1.11	1.33
medulloblastoma cell line:ONS-76	10759-110E3	38.15	62.24	29.71	6.11	1.35	0.73	0.24	0.12	0.12
melanoma cell line:COLO 679	10514-107E1	18.26	54.34	31.34	5.17	0.57	0.29	0.72	0.14	0.00
melanoma cell line:G-361	10465-106H6	84.70	93.93	51.31	17.65	13.84	2.44	5.16	1.63	0.00
meningioma cell line:HKBMM	10691-109F7	46.67	22.61	34.19	1.63	0.18	2.53	0.36	0.90	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	39.65	102.21	65.21	7.05	0.00	0.88	1.76	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	19.44	76.73	36.55	9.85	0.00	0.78	0.00	1.04	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	231.07	137.94	32.99	12.12	18.41	4.45	1.23	1.69	1.38
mesenchymal precursor cell - adipose, donor2	11748-123G2	225.04	77.26	45.45	7.09	7.45	3.64	0.55	2.00	2.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	128.37	117.61	24.43	9.94	7.87	1.66	0.00	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	176.72	49.45	61.53	7.59	6.74	2.11	1.55	1.40	0.98
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	174.08	49.49	55.27	5.39	6.16	3.47	0.19	0.96	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	91.62	68.02	26.37	6.94	9.02	0.69	1.39	2.08	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	198.58	39.30	36.56	4.98	4.46	1.20	1.20	1.03	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	162.98	62.68	41.64	7.82	6.90	2.30	0.81	1.50	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	167.12	74.01	33.03	10.35	9.15	1.59	0.66	1.59	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	144.09	91.96	33.22	8.78	10.53	1.62	1.08	0.81	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	182.38	67.15	41.97	9.53	6.40	2.56	1.28	1.00	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	144.59	39.85	43.15	2.31	4.28	1.32	1.65	0.66	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	152.76	70.71	40.27	5.95	7.61	1.25	0.14	1.11	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	153.95	75.75	31.77	9.08	8.73	4.19	1.75	1.40	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	163.74	45.32	48.59	7.96	8.78	3.06	0.82	1.63	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	121.86	41.70	36.66	1.80	8.27	0.36	0.72	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	105.00	49.97	43.66	4.45	3.41	1.76	0.83	1.34	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	88.92	48.33	35.34	2.96	3.65	1.60	0.91	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	130.06	120.83	44.05	5.45	4.20	2.52	1.26	1.68	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	166.92	56.64	39.15	6.87	5.38	2.39	0.90	1.20	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	139.70	59.61	39.74	5.86	3.85	2.80	1.14	1.31	1.40
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	141.74	39.02	40.50	4.05	2.21	2.95	0.00	0.74	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	124.48	46.64	46.93	3.15	4.86	1.14	1.43	1.43	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	57.26	95.57	26.52	7.16	4.21	3.79	0.42	2.53	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	161.66	56.63	32.42	5.02	5.94	1.83	0.46	1.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	153.47	107.43	37.09	6.14	8.70	2.56	2.05	2.05	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	174.85	104.18	38.48	4.97	9.42	2.36	2.09	1.31	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	160.21	85.65	35.74	9.55	10.47	3.08	2.46	1.23	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	151.57	106.38	28.71	7.53	9.41	2.12	1.41	0.71	2.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	164.15	95.11	40.28	5.42	8.46	0.68	2.71	2.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	150.12	95.10	20.83	7.86	8.25	1.96	2.36	0.79	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	147.36	107.51	32.90	4.63	9.27	2.32	3.24	1.39	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	144.91	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	199.30	139.02	47.01	8.36	12.40	2.60	0.87	4.33	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	171.12	105.08	42.17	6.92	11.16	1.12	1.56	1.34	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	157.91	117.29	37.74	9.61	8.17	1.68	1.68	0.72	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	211.20	115.87	49.13	7.33	13.20	3.67	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	144.67	99.69	38.26	6.71	6.71	2.35	0.67	1.01	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	142.46	99.89	29.07	11.05	5.73	2.05	1.23	0.41	2.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	158.94	109.97	31.36	3.87	8.16	1.29	1.72	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	177.74	98.44	43.75	5.47	8.20	2.73	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	165.28	67.14	36.15	5.16	10.33	10.33	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	194.22	97.11	41.25	6.50	7.47	2.27	1.62	2.27	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	234.25	106.21	64.02	2.91	5.82	2.91	2.91	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	211.10	102.88	41.58	9.60	9.60	3.73	1.07	1.07	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	199.54	90.77	47.43	0.82	7.36	3.27	1.64	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	183.09	83.96	45.09	8.16	7.00	1.94	0.78	2.33	2.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	180.49	62.96	54.57	6.30	12.59	4.20	0.00	2.10	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	168.89	85.44	41.73	6.95	5.96	2.98	0.99	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	176.39	85.81	14.30	0.00	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	169.59	91.91	37.95	8.30	2.96	2.37	1.19	0.00	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	199.83	97.48	53.61	6.09	7.31	1.22	3.66	1.22	4.87
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	216.42	54.10	54.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	203.32	114.01	50.67	8.23	6.97	2.53	1.27	0.63	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	197.29	72.43	58.98	5.86	6.90	1.38	1.03	0.34	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	214.92	79.52	47.28	4.30	8.60	2.15	2.15	0.00	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	119.75	67.86	31.93	0.00	3.99	3.99	3.99	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	158.42	27.55	30.99	0.00	0.00	3.44	3.44	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	171.14	44.01	39.12	2.85	9.78	2.85	1.63	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	166.04	53.23	38.93	2.38	6.36	3.97	1.59	0.00	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	139.72	42.45	32.42	1.18	2.36	2.95	1.77	1.18	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	141.83	43.33	31.79	2.49	4.68	3.12	1.56	0.94	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	130.99	29.41	37.43	1.34	1.34	4.01	2.67	1.34	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	67.41	55.59	16.56	1.18	4.73	1.18	1.18	1.18	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	79.61	53.93	30.82	2.57	5.14	7.70	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	91.56	50.25	37.17	4.82	4.82	1.38	0.69	0.69	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	48.00	77.68	25.73	6.93	3.96	2.97	0.49	0.49	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	43.74	63.93	28.04	4.49	2.24	1.12	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	50.25	69.33	32.44	5.09	7.00	1.91	0.64	1.91	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	31.84	56.42	31.03	8.06	4.84	0.81	0.40	0.40	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	47.97	56.70	30.53	10.90	8.72	2.18	0.00	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	55.75	65.89	27.88	10.14	3.80	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	81.93	55.83	37.02	4.25	1.82	0.61	0.61	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	81.34	49.71	45.19	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	68.37	51.07	39.54	5.77	3.29	4.12	1.65	1.65	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	65.08	52.38	35.52	3.17	4.76	0.60	0.20	0.00	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	70.09	46.40	33.42	2.60	4.87	0.65	0.65	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	96.77	52.97	32.60	3.06	5.09	2.04	1.02	2.04	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	210.45	40.23	97.49	0.00	10.83	0.77	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	174.11	115.52	58.35	11.34	10.87	0.47	0.24	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	159.62	53.75	46.80	1.62	4.17	1.16	0.46	0.70	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	64.10	81.20	12.82	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	46.55	70.90	10.07	3.49	0.72	5.03	0.82	2.06	0.51
mesothelioma cell line:Mero-25	10850-111F4	25.87	43.80	37.90	4.31	0.23	1.59	0.00	0.45	0.68
mesothelioma cell line:Mero-41	10851-111F5	128.59	104.39	26.65	4.89	4.65	2.69	1.22	1.96	0.98
mesothelioma cell line:Mero-48a	10852-111F6	67.09	86.36	41.41	9.74	3.99	2.44	0.89	1.77	0.22
mesothelioma cell line:Mero-82	10853-111F7	58.08	51.77	23.65	8.94	0.26	1.31	0.53	1.31	0.00
mesothelioma cell line:Mero-83	10854-111F8	100.60	69.28	26.04	10.21	1.53	2.89	1.19	1.70	0.51
mesothelioma cell line:Mero-84	10855-111F9	75.07	112.23	21.99	7.33	0.51	1.77	0.76	1.77	1.01
mesothelioma cell line:Mero-95	10856-111G1	73.71	68.74	32.09	6.63	2.90	2.48	1.45	1.04	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	87.63	92.43	37.60	10.93	2.82	2.15	0.50	1.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	68.23	61.36	13.03	5.97	2.53	1.27	0.90	0.00	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	72.60	50.05	24.77	7.86	1.88	1.54	0.68	1.37	0.34
mesothelioma cell line:NCI-H28	10845-111E8	46.57	73.54	26.72	9.16	1.02	1.53	1.27	0.00	0.25
mesothelioma cell line:No36	10857-111G2	32.62	47.63	20.22	7.18	0.98	0.65	0.33	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	135.48	55.00	23.30	6.23	1.35	2.17	0.54	1.08	0.54
migratory langerhans cells, donor1	11901-125F2	75.23	128.97	21.88	9.60	2.49	0.19	0.96	0.96	0.38
migratory langerhans cells, donor2	11902-125F3	50.31	72.54	43.84	6.35	1.71	0.98	0.49	0.12	0.37
migratory langerhans cells, donor3	11903-125F4	48.46	51.33	47.56	7.36	1.08	0.36	0.54	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	36.57	21.55	39.83	1.63	1.63	2.29	0.65	2.94	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	35.82	65.28	31.79	0.85	3.81	1.06	0.64	1.70	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	132.46	58.97	91.68	5.99	1.38	0.92	0.46	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	22.26	36.35	13.51	4.00	0.38	0.19	0.38	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	45.83	70.41	39.73	11.27	3.33	1.11	0.18	0.00	0.18
myeloma cell line:PCM6	10474-106I6	16.60	49.61	30.44	1.78	5.14	0.20	0.00	0.59	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	41.09	30.44	20.80	1.01	0.00	0.00	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	60.80	14.32	25.11	3.73	2.94	0.78	0.39	0.39	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	52.70	36.21	66.74	7.24	0.89	0.67	0.11	0.22	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	39.64	38.90	50.60	6.99	0.96	0.29	0.15	0.00	0.22
nasal epithelial cells, donor2	12227-129F4	113.16	91.08	57.96	5.52	0.00	0.55	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	80.06	110.66	169.32	3.45	0.00	0.46	0.69	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	60.43	89.24	52.57	19.83	1.12	0.19	0.19	0.56	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	89.63	24.67	60.95	2.74	0.21	1.69	0.84	1.48	0.42
neuroblastoma cell line:NH-12	10555-107I6	92.24	62.05	81.06	3.54	0.19	1.30	0.93	0.19	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	58.59	64.05	82.32	1.19	0.24	4.27	0.95	0.71	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	65.73	68.90	71.75	1.43	0.95	3.80	1.58	0.95	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	102.04	107.67	53.94	6.64	0.60	1.01	0.20	0.60	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	109.35	54.68	118.25	1.91	0.00	0.00	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	280.54	74.53	50.04	3.99	4.26	1.60	0.53	0.53	1.06
neutrophil PMN, donor1	12133-128D9	14.87	14.87	74.37	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	66.29	0.00	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	66.13	50.91	16.91	4.74	2.71	0.68	0.51	0.34	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	17.61	32.82	49.63	4.80	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	175.05	52.90	62.20	4.49	10.58	4.81	3.21	2.24	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	103.00	64.64	43.62	4.99	4.73	2.89	1.31	0.53	1.84
nucleus accumbens, adult, pool1	10037-101F1	15.56	92.33	83.80	8.34	1.31	0.28	0.19	0.19	0.09
occipital cortex - adult, donor10196	10172-103C1	2.06	47.39	49.45	8.24	0.00	2.06	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	43.47	61.99	50.45	3.49	0.27	1.07	0.81	1.07	0.54
occipital cortex, newborn, donor10223	10355-105E4	11.28	52.41	42.58	1.46	0.36	0.36	1.46	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	12.33	48.54	65.60	6.04	0.00	1.05	0.79	1.05	0.79
occipital lobe, fetal, donor1	10073-102A1	5.15	37.33	72.95	0.00	0.00	0.00	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	8.28	59.37	58.89	5.76	0.00	0.24	0.00	0.00	0.16
olfactory region, adult	10195-103E6	9.17	37.06	48.72	4.39	0.38	0.57	0.38	0.19	0.38
optic nerve, donor1	10277-104E7	38.02	32.02	56.03	2.00	0.00	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	81.56	50.23	66.75	5.58	5.24	0.91	1.71	0.23	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	149.34	109.36	69.24	11.27	1.24	0.55	0.27	0.00	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	36.57	76.20	23.87	3.22	0.51	1.52	0.85	1.69	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	41.93	56.14	51.86	3.58	0.00	2.31	1.04	0.81	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	131.11	41.16	58.21	8.23	2.65	1.18	0.59	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	122.40	107.45	166.31	12.15	0.93	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	137.63	60.44	29.05	4.45	3.39	1.48	0.42	0.21	0.64
ovary, adult, pool1	10020-101D2	71.89	65.60	77.66	4.37	2.97	0.17	0.79	0.26	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	90.74	57.20	42.53	3.48	3.30	1.83	0.73	0.37	0.55
pancreas, adult, donor1	10049-101G4	803.31	113.82	135.45	3.76	53.62	9.41	0.94	5.64	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	18.73	46.68	13.14	2.24	2.52	0.56	0.28	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	30.83	63.88	17.04	7.84	1.87	2.56	0.85	0.85	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	54.48	84.45	42.39	6.79	1.66	0.66	0.17	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	13.27	79.99	76.97	9.24	0.18	0.82	0.27	0.09	0.18
parietal cortex, adult, donor10258	10373-105G4	62.39	74.87	24.22	7.34	0.00	1.47	0.00	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	4.70	45.14	48.91	6.58	0.00	0.00	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	17.67	46.18	45.89	4.56	0.29	0.57	0.57	0.00	0.57
parietal lobe, adult, pool1	10034-101E7	13.66	76.84	72.70	10.05	0.53	0.88	0.18	0.09	0.09
parietal lobe, fetal, donor1	10072-101I9	7.76	41.70	66.92	1.94	0.00	0.00	3.88	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	24.30	55.33	40.75	2.24	0.75	0.37	0.37	0.00	0.37
parotid gland, adult	10199-103F1	456.33	162.18	87.57	3.08	63.52	4.93	5.55	1.23	1.85
penis, adult	10200-103F2	42.43	71.97	47.27	1.61	1.07	2.15	2.69	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	71.96	73.07	91.48	1.67	0.74	1.86	0.93	0.74	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	99.51	66.44	64.98	4.37	4.23	2.19	0.44	0.58	0.87
pineal gland - adult, donor10196	10179-103C8	18.06	30.32	26.45	4.52	2.58	1.29	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	31.98	76.40	39.68	8.29	3.55	0.59	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	15.05	23.20	13.80	1.88	1.25	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	119.39	44.52	52.61	9.11	18.21	2.02	3.04	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	143.85	104.76	93.81	15.11	31.79	2.61	1.56	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	57.88	42.56	48.52	0.85	21.28	2.55	0.00	4.26	0.85
placenta, adult, pool1	10021-101D3	74.82	111.48	38.16	6.13	8.28	0.54	0.54	0.11	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	57.47	37.87	23.44	3.18	0.79	1.32	0.66	0.53	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	190.50	69.73	99.14	5.91	5.14	1.09	0.78	0.93	1.09
pons, adult, pool1	10033-101E6	15.41	59.39	53.28	14.89	0.52	0.34	0.17	0.00	0.09
postcentral gyrus, adult, pool1	10032-101E5	8.63	71.83	68.08	6.80	0.00	0.44	0.17	0.26	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	94.11	20.91	269.79	2.09	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	38.56	27.54	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	35.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	50.25	78.07	58.12	8.30	3.35	1.60	0.44	1.17	0.44
prostate cancer cell line:PC-3	10439-106E7	90.57	106.18	67.70	10.89	6.17	1.82	1.09	0.54	0.18
prostate, adult, pool1	10022-101D4	74.73	55.78	46.71	2.00	6.08	0.82	1.00	0.27	0.00
putamen, adult, donor10196	10176-103C5	12.04	82.39	63.97	4.96	0.24	0.71	0.47	1.42	0.24
putamen, adult, donor10252	10152-102I8	15.69	37.25	52.94	0.00	0.00	0.00	1.96	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	55.73	16.39	8.74	0.00	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	7.25	51.95	50.01	6.04	0.00	0.72	0.48	0.97	0.24
putamen, newborn, donor10223	10365-105F5	21.74	99.70	18.74	0.75	0.75	0.75	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	118.12	64.59	31.13	1.75	0.58	0.58	0.58	0.58	0.29
rectum, fetal, donor1	10067-101I4	95.98	59.81	109.89	1.39	2.78	0.00	5.56	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	58.51	46.22	39.64	1.27	4.88	0.42	0.21	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	31.89	36.86	8.70	1.66	4.97	0.41	0.41	0.41	0.41
retina, adult, pool1	10030-101E3	50.40	60.43	71.97	5.37	5.47	0.40	0.89	0.30	0.30
retinoblastoma cell line:Y79	10475-106I7	135.10	106.26	42.61	21.56	0.26	0.78	1.04	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	89.51	115.57	38.36	5.29	1.84	0.49	0.61	0.49	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	224.40	159.44	49.21	5.06	4.22	1.41	0.28	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	270.55	53.81	76.54	4.55	2.27	1.52	2.27	0.00	0.76
salivary acinar cells, donor1	11771-123I7	157.49	41.27	39.82	2.43	4.86	1.78	0.97	1.62	0.81
salivary acinar cells, donor2	11772-123I8	155.17	53.56	31.26	1.38	2.89	2.62	3.30	1.51	0.96
salivary acinar cells, donor3	11773-123I9	146.98	34.43	33.10	0.66	1.99	1.32	1.32	0.00	0.66
salivary gland, adult, pool1	10093-102C3	310.57	145.28	85.79	10.30	50.90	2.86	0.57	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	68.88	120.99	46.12	8.26	3.54	0.93	0.59	0.08	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	60.77	98.51	46.43	7.17	1.76	0.82	0.71	0.71	0.00
seminal vesicle, adult	10201-103F3	107.40	67.19	26.45	2.12	9.52	5.82	4.23	2.12	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	34.74	30.85	16.03	1.70	4.37	0.73	0.00	0.73	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	108.20	49.82	35.73	2.26	0.50	2.26	0.25	1.01	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	99.35	116.41	34.12	11.04	2.01	1.00	1.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	136.60	107.46	56.55	4.03	6.31	2.42	0.67	0.54	1.61
signet ring carcinoma cell line:Kato III	10436-106E4	24.76	98.37	37.03	7.74	0.11	0.55	0.44	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	114.45	146.31	29.16	5.94	3.74	0.65	0.65	0.26	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	16.31	129.81	120.59	5.67	1.42	0.71	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	32.26	215.29	145.00	10.31	0.84	1.32	0.96	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	79.40	71.36	97.49	2.01	3.02	1.01	3.02	1.01	0.00
skin, adult, donor1	10074-102A2	88.21	27.14	27.14	0.00	6.79	0.00	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	124.98	64.39	74.48	3.16	10.10	2.52	1.89	6.31	5.05
small cell cervical cancer cell line:HCSC-1	10800-110I8	21.68	95.05	33.69	10.67	0.33	1.00	0.00	1.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	47.60	64.30	29.63	5.67	0.00	1.26	0.63	0.63	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	80.38	121.82	50.50	8.48	4.82	1.35	1.54	0.96	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	104.17	65.60	118.51	8.57	0.00	0.82	0.33	0.82	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	81.23	88.31	19.78	16.73	0.32	1.13	0.80	0.32	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	74.09	85.86	40.75	5.67	1.53	0.87	0.87	0.22	0.44
small intestine, adult, pool1	10024-101D6	57.69	123.38	74.17	4.66	2.63	0.84	2.51	0.60	0.12
small intestine, fetal, donor1	10064-101I1	64.13	62.41	36.36	1.47	4.18	5.41	0.49	1.72	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	63.60	64.11	43.08	3.08	1.03	2.05	2.05	0.00	2.05
smooth muscle, adult, pool1	10048-101G3	47.81	31.53	52.21	1.03	1.55	1.81	0.00	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	198.34	33.77	65.40	0.00	2.41	0.54	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	25.46	35.10	46.11	1.61	0.92	0.92	1.15	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	53.62	54.80	41.79	1.97	0.00	0.39	0.39	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	8.99	23.52	15.22	0.69	0.00	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	55.50	44.52	79.28	3.66	4.88	0.61	0.61	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	40.41	80.36	25.72	5.97	1.84	1.38	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	265.40	87.67	59.14	4.33	7.77	1.49	0.90	0.45	0.15
spleen, adult, pool1	10025-101D7	43.28	49.23	30.73	2.97	2.42	0.11	0.77	0.55	0.00
spleen, fetal, pool1	10044-101F8	54.35	60.07	36.71	2.38	3.34	0.24	0.16	0.16	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	28.26	129.49	19.87	7.35	3.42	0.83	0.00	0.31	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	77.47	66.08	50.51	2.66	4.18	0.95	0.00	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	58.71	86.31	44.38	3.49	7.34	3.15	2.10	2.80	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	23.85	52.38	57.08	1.17	1.95	0.39	0.39	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	12.16	157.81	76.77	11.26	8.10	1.24	0.45	0.68	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	19.49	37.28	19.06	0.85	0.00	0.42	0.42	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	130.73	69.81	44.85	5.92	1.27	1.27	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	122.82	46.99	69.42	2.14	2.14	0.00	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	205.09	67.79	83.74	4.56	33.04	5.13	1.71	1.71	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	108.55	0.00	0.00	54.27	0.00	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	50.06	54.63	36.97	1.87	0.42	1.25	0.83	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	5.69	19.66	35.17	6.21	0.00	0.52	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	26.14	66.42	25.44	2.83	1.41	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	36.68	111.19	77.26	6.42	5.27	0.69	0.46	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	10.43	63.83	69.26	5.68	0.34	0.25	0.25	0.25	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	10.68	37.75	68.38	0.71	0.71	1.42	0.00	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	8.79	39.12	49.67	3.96	0.88	0.00	0.44	0.00	0.88
tenocyte, donor1	11763-123H8	226.57	79.25	38.05	4.54	12.22	9.43	3.84	3.49	2.79
tenocyte, donor2	11765-123I1	113.69	30.52	58.75	4.20	4.96	3.82	0.76	1.14	2.29
tenocyte, donor3	11768-123I4	156.79	67.09	35.21	5.93	10.38	4.82	1.48	0.37	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	35.01	128.15	43.17	12.24	0.51	1.53	0.85	0.34	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	52.10	46.09	43.01	9.71	0.62	1.39	1.23	0.62	0.62
teratocarcinoma cell line:PA-1	10807-111A6	54.55	75.78	50.21	14.26	0.46	1.24	0.77	0.62	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	37.58	99.78	24.12	10.28	0.38	0.63	0.89	0.25	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	10.21	111.18	38.20	6.05	0.38	0.76	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	21.70	109.06	21.38	6.33	0.33	0.65	0.33	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	8.79	133.21	27.36	6.51	0.00	3.26	1.63	1.30	0.98
testis, adult, pool1	10026-101D8	55.30	182.86	56.91	79.13	3.33	1.50	2.90	0.43	0.54
testis, adult, pool2	10096-102C6	22.10	189.46	51.42	101.95	4.96	6.77	2.26	1.80	3.16
thalamus - adult, donor10196	10168-103B6	27.60	37.54	34.22	0.00	1.10	0.00	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	39.23	63.14	44.38	1.72	0.31	1.56	0.78	0.63	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	10.78	80.06	35.41	10.78	0.00	4.62	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.06	34.26	30.96	2.47	0.33	0.16	0.16	0.66	0.00
thalamus, newborn, donor10223	10366-105F6	21.29	63.29	18.41	3.45	0.58	1.15	0.00	0.58	0.00
throat, adult	10209-103G2	70.41	97.87	71.41	3.99	5.99	0.75	1.00	0.75	1.25
throat, fetal, donor1	10061-101H7	69.17	52.41	67.04	2.13	3.05	1.52	0.91	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	80.29	102.94	107.91	4.57	0.40	1.99	0.20	0.79	0.40
thymus, adult, pool1	10027-101D9	10.24	66.01	45.13	7.65	0.89	0.30	0.70	0.20	0.20
thymus, fetal, pool1	10043-101F7	29.09	67.75	42.08	5.40	1.04	0.21	0.31	0.00	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	88.15	91.21	31.11	4.79	1.46	1.86	0.66	0.93	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	53.36	47.22	59.93	5.87	0.28	0.98	0.14	0.42	0.28
thyroid, adult, pool1	10028-101E1	92.94	106.19	48.99	4.57	4.20	1.21	0.65	0.19	0.28
thyroid, fetal, donor1	10060-101H6	55.63	62.22	65.39	1.05	5.80	1.58	0.26	0.53	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	80.07	33.88	55.43	0.00	15.40	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	45.59	108.85	71.40	3.72	3.95	2.79	2.56	1.40	1.86
tongue, fetal, donor1	10059-101H5	48.08	81.18	68.97	2.76	3.94	3.15	0.00	0.79	0.79
tonsil, adult, pool1	10047-101G2	88.35	91.16	55.40	2.50	8.41	0.60	0.40	0.00	0.30
trachea, adult, pool1	10029-101E2	127.93	89.08	53.58	6.30	11.04	0.90	0.74	0.33	0.08
trachea, fetal, donor1	10058-101H4	138.11	74.63	80.40	2.69	10.77	3.08	0.38	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	148.09	80.42	25.86	10.63	6.02	2.83	1.77	1.42	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	83.48	70.52	54.20	6.79	1.01	0.41	0.41	0.10	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	178.00	128.95	85.55	15.83	1.25	3.45	3.45	1.57	0.47
tridermal teratoma cell line:HGRT	10694-109G1	264.45	60.88	81.81	1.90	5.71	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	85.33	54.77	54.94	3.89	1.10	1.52	0.68	0.42	0.08
umbilical cord, fetal, donor1	10057-101H3	98.07	31.30	62.60	4.17	4.17	0.00	2.09	0.00	4.17
uterus, adult, pool1	10100-102D1	61.60	69.10	68.08	4.78	3.58	0.34	0.51	0.34	0.17
uterus, fetal, donor1	10055-101H1	112.62	63.99	83.44	2.05	2.56	2.56	2.05	1.54	0.00
vagina, adult	10204-103F6	85.94	36.19	32.31	3.88	0.00	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	31.35	37.26	40.77	1.75	2.41	0.66	0.44	0.66	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	53.67	48.60	14.42	2.67	1.34	1.87	0.53	0.53	0.00